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In Brief
Dawes et al. show that CASPR2, the
target of an autoimmune pain disorder,
regulates sensory function through tuning
of primary afferent excitability. Human
autoantibodies to CASPR2 cause pain-
related hypersensitivity and enhance
DRG cell excitability through reduced Kv1
channel function.nc.
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https://doi.org/10.1016/j.neuron.2018.01.033SUMMARY
Human autoantibodies to contactin-associated
protein-like 2 (CASPR2) are often associated with
neuropathic pain, and CASPR2 mutations have
been linked to autism spectrum disorders, in which
sensory dysfunction is increasingly recognized.
Human CASPR2 autoantibodies, when injected
into mice, were peripherally restricted and re-
sulted in mechanical pain-related hypersensitivity
in the absence of neural injury. We therefore inves-
tigated the mechanism by which CASPR2 modu-
lates nociceptive function. Mice lacking CASPR2
(Cntnap2/) demonstrated enhanced pain-related
hypersensitivity to noxious mechanical stimuli,
heat, and algogens. Both primary afferent excit-
ability and subsequent nociceptive transmis-
sion within the dorsal horn were increased in
Cntnap2/ mice. Either immune or genetic-
mediated ablation of CASPR2 enhanced the excit-
ability of DRG neurons in a cell-autonomous
fashion through regulation of Kv1 channel expres-
sion at the soma membrane. This is the first
example of passive transfer of an autoimmune
peripheral neuropathic pain disorder and demon-
strates that CASPR2 has a key role in regulating
cell-intrinsic dorsal root ganglion (DRG) neuron
excitability.806 Neuron 97, 806–822, February 21, 2018 ª 2018 The Author(s). P
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Autoantibodies against contactin-associated protein-like 2
(CASPR2-Abs) have been linked to a number of clinical syn-
dromes. These include neuromyotonia, in which there is clinical
and electrophysiological evidence of excessive motor unit activ-
ity due to enhancedmotor axon excitability; Morvan’s syndrome,
in which neuromyotonia is associated with autonomic and CNS
dysfunction (particularly insomnia); and limbic encephalitis,
which is characterized by cognitive impairment and epilepsy
(Irani and Vincent, 2016). A common feature described in pa-
tients seropositive for CASPR2-Abs is the presence of neuro-
pathic pain, and in some patients this was the sole presenting
symptom (Irani et al., 2012; Klein et al., 2012; Lancaster et al.,
2011). Furthermore, immunosuppression to reduce levels of
CASPR2-Ab can lead to a reduction in neuropathic pain (Klein
et al., 2012). Whether CASPR2 has a direct role in nociceptive
signaling and the mechanisms by which such CASPR2-Abs
could drive neuropathic pain are unknown.
CASPR2 is a neuronal adhesion molecule of the neurexin su-
perfamily that is known to form a protein complex with shaker-
type voltage-gated potassium channels (such as Kv1.1 and
Kv1.2) (Horresh et al., 2008). CASPR2 is, therefore, one of a
group of proteins that form the voltage-gated potassium channel
complex (VGKCC) that also includes LGI1 and contactin-2 (Irani
et al., 2010). Antibodies to the VGKCC are not directed against
Kv1 channels themselves but to proteins with which they form
a complex (Irani et al., 2010). Of the components of this complex,
it is particularly antibodies to CASPR2 that have been associated
with neuropathic pain (Irani et al., 2012; Klein et al., 2012).ublished by Elsevier Inc.
commons.org/licenses/by/4.0/).
The extracellular domain of CASPR2 binds to Contactin-2 and
is required for the correct longitudinal localization of Kv1 chan-
nels to the juxtaparanode (JXP) of myelinated axons (Poliak
et al., 2003). In mice lacking CASPR2 or Contactin-2, Kv1 chan-
nels were no longer clustered at the JXP. The functional implica-
tions of this mislocalization have hitherto been unclear because,
in the naive state, Kv1 channels at the JXP are electrically iso-
lated from the node of Ranvier and paranode by compactmyelin,
and axonal excitability was reported to be unaltered in these
mice (Poliak et al., 2003). Following injury to myelin or the distal
axon, however, Kv1 channels (and CASPR2) are redistributed to
the paranode and can suppress axonal hyperexcitability (Calvo
et al., 2016; Rasband et al., 1998). Kv1.1 and Kv1.2 also have
important roles in modulating somatic excitability of DRG neu-
rons (Gold et al., 1996; Hao et al., 2013; Zhao et al., 2013). How-
ever, although CASPR2 is known to regulate longitudinal
clustering of Kv1 channels along myelinated fibers, its function
in trafficking Kv1 channels to the dorsal root ganglion (DRG)
soma membrane and the effects on excitability are unknown.
CASPR2 has also been identified as a synaptic protein with a
role in synapse development/maintenance and has recently
been linked to neurodevelopmental processes (Rodenas-Cua-
drado et al., 2014): humans with homozygous loss-of-function
mutations in CNTNAP2 (the gene encoding CASPR2) develop
epilepsy and developmental delay with a number of core fea-
tures of autistic spectrum disorder (ASD) (Strauss et al., 2006).
Mice lacking CASPR2 have been shown to develop autistic traits
at a behavioral level, associated with deficits in the migration of
cortical inhibitory interneurons (Pen˜agarikano et al., 2011). So-
matosensory abnormalities have recently been recognized as a
common feature of ASDs (Cascio, 2010) and are now part of
diagnostic criteria. Given the reported association of CASPR2-
Abs with pain as well as the increasing recognition of somato-
sensory abnormalities as a core feature of ASDs, we undertook
a detailed characterization of the role of CASPR2 in the regula-
tion of sensory function.
RESULTS
Patient CASPR2-Abs Cause Pain-Related
Hypersensitivity in Mice
To investigate the potential pathogenicity of CASPR2-Abs, we
injected mice with patient-derived purified IgG (obtained from
two CASPR2-Ab-positive patients with neuropathic pain who
had received plasma exchange treatment) and assessed pain-
related behavior. Patient 1 had Morvan’s syndrome with typical
features of neuromyotonia, dysautonomia, pain, and severe
insomnia. He improved considerably with plasma exchange
(that reduces circulating antibody levels by >80%) (Liguori
et al., 2001). Patient 2 presented with cerebellar ataxia and
neuropathic pain that was particularly localized to the feet; there
was, however, no clinical or electrophysiological evidence of
neuromyotonia (patient 2 information shown in Data S1). The
antibodies in patient 1 were originally identified by radioimmu-
noprecipitation of VGKC complexes from rabbit brain tissue,
but were then shown to be directed against CASPR2 using a
live cell-based assay (CBA) (Irani et al., 2010). Both patients
1 and 2 had very high titers of CASPR2 IgG in their sera, plasmas,and purified IgG preparations (1:62,500 or higher; Figure 1A). An-
tibodies to LGI1, the other main VGKC complex protein, were
only just detectable (1:20) in patient 1 IgG and negative in patient
2 IgG.
We gavemice systemic injections of purified patient IgG or IgG
from a healthy control for either 14 or 22 days (dosing and behav-
ioral testing regime is shown in Figure 1B). At theendof the exper-
iment, the CASPR2-IgG-treated mice had very high CASPR2
titers (maximal binding at 1:100, titrating out to 1:12,500 or
higher). No LGI1 antibodies were detected in the mice. Over the
course of the experiment, there was no significant weight loss
compared to baseline or between groups (Figures S1A and
S1D). Mice treated with purified IgG from patient 1 developed
a significant delayed-onset mechanical hypersensitivity when
compared to control IgG-treated mice, beginning after 11 days
of injections (withdrawal threshold to von Frey hair of 0.58 ±
0.04 g control IgG versus 0.41 ± 0.09 g patient 1 IgG) (Figure 1C),
with a greater effect seen after 14 days (0.6 ± 0.05 g control IgG
versus 0.31 ± 0.05 g patient 1 IgG) (Figure 1C). Mice treated
with purified IgG from patient 2 also developed a delayed-onset
mechanical hypersensitivity, which was significantly different
from the control IgG group 15 days after the initial injection
(0.6 ± 0.1g control IgG versus 0.32 ± 0.07 g patient 2 IgG) (Fig-
ure 1E). Although a significant reduction in thermal withdrawal
thresholds was seen for mice treated with patient 2 IgG at day
15 (Figure 1F), in general thermal thresholdswere similar to those
of control mice (Figures 1D and 1F). We found no difference be-
tween treatment groups in spontaneous locomotor activity or
rearing behavior in the open field test (Figures S1B and S1E,
and S1C and S1F, respectively). We did not observe any sponta-
neous nocifensive behavior such as licking, biting, or paw-lifting.
Patient CASPR2-Abs Bind In Vivo but Do Not Cause
Overt Inflammation or Substantial Damage to the
Nervous System
Using anti-human IgG antibodies to detect bound IgG, we as-
sessed CASPR2-Ab deposition in tissue taken from the mice.
No immunoreactivity for human IgG was found in the spinal
cord (Figure 2A), suggesting that patient IgG did not cross the
blood-cord barrier. We did see some human IgG deposited in
the sciatic nerve (Figure S2A), but did not see any specific bind-
ing to the JXP. A previous study using patient CASPR2-Abs also
did not see binding to axons in intact nerve, suggesting that Abs
are unable to cross the tight junction at the paranode to access
their target within the JXP (Manso et al., 2016). This is in stark
contrast to permeabilized frozen nerve sections, where clear
binding in the JXP can be seen (Figure S2B). At the level of the
DRG, however, CASPR2 is more easily accessible on the
neuronal soma and clear binding of human IgG can be seen on
the surface of sensory neurons (Figure 2B); this suggests that
the ability of CASPR2 to increase pain-related behavior in mice
could be due to its action in the peripheral nervous system,
particularly at the level of the DRG.
CASPR2-Ab could cause neuropathic pain as a consequence
of neuro-inflammation. To address this, we assessed cellular
infiltration of neutrophils, macrophages, and lymphocytes, using
the markers Ly6G, IBA1, and CD3, respectively, in the DRG.
There was no difference in any of thesemarkers between controlNeuron 97, 806–822, February 21, 2018 807
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Figure 1. Passive Transfer of Human
CASPR2-Abs Causes Pain-Related Hyper-
sensitivity in Mice
(A) CBA showing binding of antibodies from patient
plasma using an anti-human IgG secondary anti-
body (red) to HEK cells transfected with human
CASPR2-EGFP. No binding is seen using plasma
from a healthy control subject. Scale bar, 50 mm.
(B) Dosing regime and behavioral time course for
passive transfer of WT mice with purified IgG from
CASPR2-Ab-positive patients.
(C–F) Using von Frey hairs, mice treated with patient
1 and 2 IgG develop a significant mechanical pain-
related hypersensitivity (C and E, respectively) when
compared to mice treated with IgG from a healthy
control subject. Mice did not, however, develop a
clear thermal hypersensitivity using the Hargreaves
testing method (D and F). For (C) and (D), n = 8, and
for (E) and (F), n = 9.
Data shown as mean ± SEM, *p < 0.05, **p < 0.01
versus control IgG group. See also Figure S1.and patient IgG-treated mice (Figures 2D–2F and S2D–S2F).
Additionally, there was no difference in IBA1-positive cells in
the sciatic nerve between treatment groups (Figures 2C and
S2C). We also measured the expression of a number of cyto-
kines and chemokines in the DRG and nerve using qPCR and808 Neuron 97, 806–822, February 21, 2018saw no significant differences between an-
imals treated with patient IgG versus con-
trol (Table S1).
Similarly, we did not observe a signifi-
cant inflammatory response within the spi-
nal cord. There were no Ly6G-positive
cells in the spinal cord (Figures S3A and
S3B). Counts for CD3-positive cells were
low and no difference was found between
treatment groups (Figures S3C and S3D).
We also saw no evidence of astrocytosis
as measured using GFAP (Figures S3E
and S3F). Although we observed a small
but significant increase in the density of
IBA1-positive microglia in the spinal cord
in mice treated with patient 1 IgG (Fig-
ure S3G), we did not see any differences
for patient 2-treated mice (Figure S3H).
Recent work has shown that exposure of
mice in utero to CASPR2-Abs can cause
microglia activation in specific brain re-
gions (Coutinho et al., 2017). Therefore,
we assessed microglia in the primary so-
matosensory cortex, but saw no difference
in microglia in terms of both cell density
and morphology (Figures S3I–S3O). These
data, coupled with lack of weight loss (Fig-
ures S1A and S1D), suggest that patient
autoantibodies did not cause a gross in-
flammatory response.
To investigate possible Ab-mediated
neural injury, wemeasured intra-epidermalnerve fiber density (IENFD) in the paw that did not differ between
animals treated with IgG from either healthy control or CASPR2-
Ab-positive patients (Figures 2G and S2G). This is in line with pa-
tient data describing normal IENFD density (Data S1). Activating
transcription factor 3 (ATF3) is upregulated by sensory neurons
A B
C D
E F
G H
I J
(legend on next page)
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following injury (Tsujino et al., 2000). No difference was found in
DRG neuronal ATF3 expression from control and patient 2 IgG-
treated mice (Figure 2H); a small but significant increase in
ATF3 immunoreactive DRG profiles was found in mice treated
with IgG from patient 1 (Figure S2H) and may explain the small
increase in microglial density observed in Figure S3G. We also
assessed the structure of peripheral nerve in more detail using
electron microscopy (EM). We saw no evidence of autoanti-
body-mediated demyelination. G ratios were the same between
the control and patient IgG-treated groups (Figures S4A–S4C
and S4E), and there were no significant differences in axon diam-
eter or the total number of axons (Figures S4D, S4F, and S4G;
Table S2). We also studied the organization of nodal sub-do-
mains. No differences were seen in the total number of nodes
(Figures S4H and S4K), or in those nodes containing CASPR2
or Kv1.1 comparing between treatment groups (Figures S4I,
S4J, S4L, and S4M). However, when CASPR2 and Kv1.1 immu-
nostaining was assessed there was a significant reduction in the
immunopositive area in those animals treated with patient IgG
when compared to controls (Figures 2I, 2J, S4N, and S4O).
Therefore, it seems that the pain-related phenotype seen in
mice treated with patient IgG was not due to any gross structural
injury or inflammation of the peripheral or CNS. The patient auto-
antibodies did, however, reduce the levels of CASPR2 and Kv1.1
protein found clustered in the JXP of axons. This reduction was
observed despite the fact that we did not detect direct binding of
patient-IgG to the JXP in vivo; we did observe patient-IgG bind-
ing at the level of the neuronal cell body within the DRG that
could deplete the total protein available. Given the lack of Ab-
mediated injury, we hypothesized that CASPR2-Abmay regulate
sensory function by reducing CASPR2 protein levels leading to
increased excitability in peripheral sensory neurons.
CASPR2 Expression in DRG Neurons
Because CASPR2-Abs were restricted to the periphery and
clearly deposited in the DRG, we initially analyzed the expression
of CASPR2 within sensory neuron sub-types. RNA in situ hybrid-
ization (ISH) showed that >99% of mouse primary sensory neu-
rons from lumbar DRG (defined as those cells that had a signal
greater than the mean background signal plus 2 SDs) expressed
CASPR2mRNA (Figure S5A). It was clear, however, that sensory
neurons expressed CASPR2 to varying degrees. Large diameter
DRG cells expressed higher levels of CASPR2 than small diam-Figure 2. Patient CASPR2-Abs Bind In Vivo but Do Not Cause Gross In
(A and B) Representative image of a spinal cord (A) and DRG (B) section from a m
spinal cord (A). In the DRG, human IgG binds to sensory neurons (B). Scale bars
(C and D) Representative images of sciatic nerve (C) and DRG (D) sections from
tification shows no difference between treatment groups; n = 4 mice. Scale bar,
(E and F) Representative images of DRG sections from mice treated with either co
positive cells was very low, and no difference was found between groups; n = 4
(G) Representative images of mouse glabrous skin. PGP9.5 (green) was used to
groups; n = 5 mice. Scale bar, 25 mm.
(H) Representative images of mouse DRG sections stained for the injury marker AT
mice. Scale bar, 50 mm.
(I and J) High-power representative images of single nodes (marked by CASPR [re
staining is reduced inmice treatedwith patient 2 IgG. Quantification shows a signifi
group versus control (J); n = 4 mice.
Data shown as mean ± SEM, *p < 0.05 versus control IgG group. See also Figur
810 Neuron 97, 806–822, February 21, 2018eter DRG cells, consistent with its known expression within
myelinated nerve fibers (Poliak et al., 2003) (Figure S5B). A com-
bination of ISH and immunohistochemistry analyses showed
that the highest level of CASPR2 expression was in cells that ex-
press NF200 (a marker of myelinated afferents including Ab and
Ad afferent mechanoreceptors) (Figures S5C and S5D). Pepti-
dergic and non-peptidergic small diameter afferents (principally
C-fiber nociceptors) can be identified through expression of
CGRP and binding of the lectin IB4, respectively. Both of these
populations clearly expressed CASPR2, albeit at a lower level
than the NF200 population (Figures S5C and S5D). Very low
levels of expression were seen in neurons immunopositive for
tyrosine hydroxylase (TH), a marker of non-nociceptive C-fibers
(Figures S5C and S5D).
CASPR2 Regulates Pain-Related Hypersensitivity
in Mice
We next investigated whether a loss of CASPR2 might alter
pain-related behavior using mice that no longer express the
full-length (FL) version of CASPR2 (Cntnap2/) (Poliak et al.,
2003). Although a short isoform lacking the majority of the extra-
cellular domain is still expressed in these mice (Figure 5F) (Chen
et al., 2015), we found that the loss of FL-CASPR2 resulted in
pain-related hypersensitivity (Figure 3). Cntnap2/ mice were
hypersensitive to von Frey hair application, demonstrating a
significantly lower withdrawal threshold compared to wild-type
(WT) littermates (Cntnap2+/+ 0.64 ± 0.06 g versus Cntnap2/
0.37 ± 0.04 g; Figure 3A). Cntnap2/ mice were also hypersen-
sitive to noxious pinprick application, which causes a rapid reflex
withdrawal response mediated by Ad fibers (Arcourt et al., 2017)
(Figure 3B).We also assessed the response to dynamicmechan-
ical stimuli, but saw no differences between genotypes (Fig-
ure 3C). There was no difference in withdrawal latency to a
radiant heat source (Hargreaves method) or the hot plate set at
50C when comparing Cntnap2/ and control mice (Figures
3D and 3E). However, when the hotplate was set at 53C there
was a significant difference between groups, with Cntnap2/
mice having a shorter latency to response (Cntnap2+/+ 10.0 ±
0.5 s versus Cntnap2/ 8.3 ± 0.4 s; Figure 3F). This suggests
that a loss of CASPR2 results in hypersensitivity to supra-
threshold noxious heat. Sensitivity to cold temperatures,
measured with a thermal preference paradigm, was unchanged
between genotypes (Figure 3G). We also tested mechanical andflammation or Nerve Damage
ouse treated with patient IgG. No deposition of human IgG (green) seen in the
, 200 mm (A), 50 mm (B).
mice treated with either control or patient 2 IgG stained for IBA1 (red). Quan-
50 mm.
ntrol or patient 2 IgG stained for Ly6G (red, E) and CD3 (red, F). The number of
mice. Scale bar, 25 mm.
mark nerve fibers. No difference was seen in the IENFD between treatment
F3 (red). Quantification showed no difference between treatment groups; n = 4
d]) frommouse sciatic nerve (I). Kv1.1 (green, top) and CASPR2 (green, bottom)
cant reduction in the area of both Kv1.1 andCASPR2 staining in the patient IgG
es S2–S4.
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Figure 3. CASPR2 Regulates Pain-Related Hypersensitivity in Mice
(A) Using von Frey hairs, Cntnap2/ (n = 15) mice display hypersensitivity to mechanical stimuli when compared to WT littermates (Cntnap2+/+, n = 20).
(B) Withdrawal latency to pinprick application is significantly reduced in Cntnap2/ (n = 14) compared to WT littermates (Cntnap2+/+, n = 12).
(C) No difference in dynamic allodynia measured following brush application to the hindpaw between genotypes (Cntnap2/, n = 8; Cntnap2+/+, n = 6).
(D–F) Cntnap2/ mice (n = 8) do not display heat hypersensitivity to threshold stimuli as measured by the Hargreaves test (D) or to the hot plate set at 50C (E).
However, when using the hot plate set at 53C (F), Cntnap2/ mice have a reduced latency to withdrawal compared to Cntnap2+/+ mice (n = 13).
(G) In comparison to WT littermates, Cntnap2/ mice do not display cold hypersensitivity as measured by the thermal preference test; n = 7 in both groups.
(H and I) In response to an intraplantar injection of capsaicin (1.5 mg), the duration of pain-related behavior is significantly greater in Cntnap2/ (n = 11) versus
Cntnap2+/+ (n = 12) mice over a 5-min period (I), but particularly in the first minute (H).
(J and K) In comparison to control mice,Cntnap2/mice have an increased response to 5% formalin. This difference is significant in the first 5 min after injection
of formalin (J), as well as in the second phase of the behavioral response (K); n = 8 for both groups.
Data shown as mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001 versus Cntnap2+/+ group. See also Figures S5 and S6.thermal sensitivity in mice heterozygous for the loss of FL-
CASPR2 (Cntnap2+/). Thresholds were not significantly altered
when compared to Cntnap2+/+ using von Frey hairs, the Har-
greaves method, or the hot plate set at 53C (Cntnap2+/
0.58 ± 0.04 g, 11.1 ± 0.43 s, 8.9 ± 0.7 s, respectively; n = 7).
Sensitivity to chemical algogens was also assessed. In
Cntnap2/ mice, intraplantar injection of capsaicin produced
a significantly augmented pain response versus WT (Figures
3H and 3I). Loss of FL-CASPR2 also resulted in enhanced no-
cifensive responses during the formalin test, both in the first
(0–15 min) and second phase (15–60 min) post-injection (Fig-
ures 3J and 3K). The initial response (0–5 min) in Cntnap2/
was significantly greater than in mice expressing FL-CASPR2(Cntnap2+/+ 162.5 ± 11.3 s versus Cntnap2/ 208.5 ±
10.5 s; Figure 3J). This difference subsided, but became
evident again in the second phase (Figures 3J and 3K).
Assessment of c-fos in the spinal cord did not reveal any dif-
ference between genotypes (Figures S6A and S6B), suggest-
ing that the increased behavioral response in the second
phase may be driven by increased primary afferent activity
(Fischer et al., 2014). Without the application of a chemical al-
gogen, no nocifensive behavior was seen in Cntnap2/ mice.
We also studied proprioception and motor behavior using the
beam test, accelerating rotarod, and open field test (Table S3).
There were no significant differences in Cntnap2/ mice
compared to controls (Table S3). However, mice lackingNeuron 97, 806–822, February 21, 2018 811
FL-CASPR2 had a significantly longer latency to fall on a
constantly moving rotarod (Table S3), suggesting they also
display some degree of motor hyperactivity in line with previ-
ous findings (Pen˜agarikano et al., 2011).
Using immunohistochemical markers, we saw no differences
in the populations of sensory neuron subtypes within the DRG
or IENFD (where the majority of fibers are nociceptors) from
Cntnap2/ mice compared to control (Figures S6C–S6F). Given
previous reports of a reduced number of cortical inhibitory inter-
neurons inCntnap2/mice (Pen˜agarikanoetal., 2011),we looked
at CASPR2 expression within the spinal cord and saw that many
Pax2-positive neurons (a marker of inhibitory interneurons) ex-
pressed CASPR2 (Figures S6G and S6H). We also confirmed its
expressionwithin inhibitory interneurons using glycine transporter
2-EGFP reporter mice (Zeilhofer et al., 2005) (Figure S6I). Quantifi-
cation of Pax2 interneurons in the dorsal horn of the spinal cord,
however, showed that numbers were unchanged between geno-
types (Figures S6J and S6K) and that there was no difference
in the number of inhibitory synapses (Figures S6L and S6M). We
also assessed gene expression in the DRGusing qPCRand found
nodifference in the transcriptionof a numberofpain-relatedgenes
(Table S4). Therefore, Cntnap2/ mice display pain-related hy-
persensitivity with nomajor anatomical or transcriptional changes
at the level of the DRG or spinal cord.
CASPR2 Regulates Sensory Neuronal Excitability and
Membrane Kv1 Channel Expression
We next used in vivo intracellular calcium imaging as a measure
of primary sensory neuron activity to see whether CASPR2
impacted neuronal excitability at the level of the cell soma.
Cntnap2/ mice and WT littermates were given intrathecal in-
jections of an AAV9 delivery vector encoding the calcium indica-
tor GCaMP6. DRG neuronal activity was indicated by a change in
fluorescent signal from baseline levels that occurred following
the application of sensory stimuli to the hindpaw (Figure 4A).
For our analysis, we separated neuronal responses by cell profile
area and found that on average both small- (<500 mm2) and me-
dium (500–1,000 mm2)-sized DRG neurons from Cntnap2/
mice exhibited larger increases in intracellular calcium following
sensory stimulation. Medium-sized DRG neurons were signifi-
cantly hyper-responsive to mechanical stimulation, both brush
and noxious pinch, applied to the hindpaw when compared to
controls (Figures 4B and 4C). Small-sized DRG neurons from
Cntnap2/ were also more responsive to pinch application, as
well as noxious heat (Figure 4D). We also measured the activity
of sensory neurons following capsaicin application and observed
that a population of medium-sized neurons from Cntnap2/
was activated by capsaicin in contrast to zero cells from WT
mice (Figure 4E). Calculation of the median cell profile size of a
capsaicin responder showed this had shifted from 234.8 mm2
in controls to 438.8 mm2 in Cntnap2/ mice with a statistically
significant shift in the population distribution (p < 0.0001, Kolmo-
gorov-Smirnov test). We also looked at spontaneous activity in
DRG neurons prior to application of sensory stimuli and found
that there was no difference between genotypes (Cntnap2+/+
8.5% ± 2.6% versus Cntnap2/ 7.3% ± 1.1%, p > 0.05, Stu-
dent’s t test). These findings are in agreement with the behavioral
phenotype (Figure 3), suggesting that CASPR2 can regulate812 Neuron 97, 806–822, February 21, 2018excitability at the level of the DRG, and we therefore used
patch-clamp analysis to assess neuronal excitability of dissoci-
ated DRG cells.
In line with in vivo calcium imaging, we found that both small-
(diameter <25 mm) and medium-sized DRG neurons (diameter
25–35 mm) from Cntnap2/ mice had significantly lower rheo-
bases than controls (Cntnap2+/+ 172.6 ± 14.9 versusCntnap2/
133.4 ± 10.9 and Cntnap2+/+ 633.6 ± 66.6pA versus Cntnap2/
446.5 ± 52.1 pA, respectively) (Figure 5A) consistent with
enhanced excitability. This was not true of large (>35 mm) diam-
eter neurons (Figure 5A). When measuring firing in response to
longer (500 ms) current injections of increasing magnitude, we
noted that small- and medium-sized Cntnap2/ neurons acti-
vated at lower thresholds and that medium neurons fired more
action potentials in response to supra-threshold stimulation
compared to Cntnap2+/+ neurons (Figure 5B). Resting biophysi-
cal properties in these neurons were normal (Table S5).
Kv1 channels contribute to IKD, a slowly inactivating voltage-
dependent potassium current that activates at potentials more
negative than the action potential threshold (Madrid et al.,
2009), positioning these channels as important regulators of
neuronal excitability. Due to their interaction with CASPR2, we
hypothesized that effects on these channels may underlie the
hyperexcitability phenotype observed in Cntnap2/ neurons.
We focused on potassium currents in medium diameter DRG
neurons as the hyperexcitability was most apparent in these
neurons.Cntnap2+/+ neurons displayed a slowly inactivating out-
ward current upon membrane potential depolarization that was
highly sensitive to a-dendrotoxin (DTX, a selective Kv1 channel
inhibitor) and therefore represents IKD carried partially by Kv1
channels (Madrid et al., 2009). IKD was significantly reduced in
medium diameter Cntnap2/ neurons compared control (Fig-
ure 5C). When tested at +40 mV, the DTX-sensitive component
of this current was also reduced in Cntnap2/ neurons (Fig-
ure 5C) (Cntnap2+/+ 143.8 ± 17.1 pA/pF versus Cntnap2/
78.6 ± 10.8 pA/pF, p < 0.01, Student’s t test), suggestive of
decreased Kv1 current. One possibility for the decrease in sensi-
tivity to DTX is that CASPR2 is important not only for the longitu-
dinal movement of these potassium channels along axons, but
also their trafficking to the cell membrane, something it has
been shown to do for other ion channels (Varea et al., 2015).
We therefore assessed the expression of Kv1.2 in culture and
found clear membrane staining of Kv1.2 in DRG neurons from
Cntnap2+/+ mice that is lost following ablation of FL-CASPR2
(Figure 5D). Profile plots show the intensity of Kv1.2 immunore-
activity across the cell body and were used to define positive
membrane expression (Figure 5D). Quantification of these
showed that 25.8% ± 3.9% of total DRG neurons from control
mice were defined as having Kv1.2 membrane expression (Fig-
ure 5E). In agreement with electrophysiological findings, Kv1.2
expression was significantly reduced to 11.3% ± 2.5% of DRG
neurons in Cntnap2/ mice (Figure 5E). Note that the mRNA
expression of Kcna2 (and Kcna1) in DRG did not differ between
Cntnap2+/+ and Cntnap2/ mice (Table S4).
We also investigated whether CASPR2 overexpression could
reverse hyperexcitability in medium DRG neurons. We observed
that in comparison to acutely cultured WT DRG neurons (1 day
in vitro [DIV]), WT neurons cultured for 5 DIV lost their Kv1.2
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Figure 4. In Vivo Calcium Imaging Shows that DRG Neurons from Cntnap2–/– Mice Are Hyper-Responsive to Mechanical and Chemical
Stimuli
(A) Representative images of GCaMP6 fluorescence as a measure of intracellular calcium following stimulation to the hindpaw. Scale bar, 100 mm.
(B) In comparison to control, DRG neurons from Cntnap2/mice had a significantly greater response to brush stimulation applied to the glabrous skin. This was
particularly true of medium-sized cells (500–1,000 mm2; Cntnap2+/+, n = 33 cells; Cntnap2/, n = 46 cells).
(C) In response to noxious pinch stimulation, there was also a significant increase in the response of DRG neurons from Cntnap2/ mice in both small- and
medium-sized neurons (<500 mm2 Cntnap2+/+, n = 106 cells; Cntnap2/, n = 132 cells; 500–1,000 mm2 Cntnap2+/+, n = 46 cells; Cntnap2/, n = 93 cells).
(D) In response to noxious heat stimulation (50C), there was a significant increase in the response of DRG neurons from Cntnap2/mice in small DRG neurons
(<500 mm2 Cntnap2+/+, n = 54 cells; Cntnap2/, n = 143 cells).
(E) No statistically significant difference was seen in the response of small cells to capsaicin application (<500 mm2; Cntnap2+/+, n = 41 cells; Cntnap2/, n = 36
cells). Note the number of medium-sized responders: Cntnap2+/+ mice = 0, Cntnap2/ mice = 23.
Cells analyzed from four Cntnap2+/+ and five Cntnap2/ mice. Data shown as mean ± SEM, **p < 0.01, ***p < 0.001 versus Cntnap2+/+ group.membrane expression (Figure S7A) and became hyperexcitable,
with a significant reduction in their rheobase (Figure 5G); interest-
ingly, we also noted reduced mRNA expression of Cntnap2 over
the same time course (Figure S7B).We therefore set out to rescue
this phenotype by overexpressing CASPR2. In addition to FL-
CASPR2, we studied the effects of the shorter isoform (SH-
CASPR2) that lacks most of the extracellular domain (Figure 5F).
qPCR showed that SH-CASPR2 is still expressed in DRG from
Cntnap2/ mice, but expression in WT DRG is 10-fold lower
than that of the main FL-CASPR2 isoform (Figures S7C and
S7D). DRG cells were electroporated with plasmids containing
either FL-CASPR2 or SH-CASPR2, both tagged with EGFP in
the cytoplasmic domain, or an EGFP plasmid control. Overex-
pression of FL-CASPR2-EGFP resulted in membranous EGFP
staining in a subset of DRG neurons (Figure S7E). At 5 DIV, SH-CASPR2-EGFP overexpression had no effect on the rheobase
(Figure 5G). By contrast, FL-CASPR2-EGFP overexpressing cells
hada significantly higher rheobase thanEGFP-expressing cells at
the same time point (EGFP 255.8 ± 32.5 pA versus FL-CASPR2-
EGFP 605.4 ± 88.9 pA; Figure 5G), and this effect was lost with
DTX treatment, suggesting that it was due to enhanced activity
of Kv1 channels (Figure 5I). Overexpression of SH-CASPR2 had
no effect on IKD (Figure 5H), whereas IKD was greater in the FL-
CASPR2-EGFP versus EGFP cells after 5 DIV and was similar to
the levels seen after 1 DIV (Figure 5H). Again, the effectwas signif-
icantly prevented by DTX (Figure 5J). The lack of effect of SH-
CASPR2 ismost likelydue to its diminishedability tobeexpressed
at the membrane (Figure S7F). Interestingly, patient CASPR2-Ab
only bound to the FL-CASPR2 isoform, and not the SH-CASPR2
isoform (Figures S8A–S8C). These data therefore suggest thatNeuron 97, 806–822, February 21, 2018 813
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Figure 5. CASPR2 Regulates the Excitability of DRG Neurons
(A) Representative traces showing action potential firing to short incremental current injection in medium (25–35 mm) diameter neurons. Small (<25 mm;
Cntnap2+/+, n = 47; Cntnap2/,n = 45 cells) and medium (25–35 mm; Cntnap2+/+, n = 20; Cntnap2/, n = 21 cells) diameter DRG neurons cultured from
Cntnap2/ mice have a significantly reduced rheobase when compared to neurons from control mice. There were no differences between genotype in large
diameter neurons (Cntnap2 +/+, n = 11; Cntnap2/, n = 13 cells).
(B) Representative traces showing action potential firing to supra-threshold prolonged current injection in small (<25 mm) and medium (25–35 mm) diameter
neurons. Quantification across a range of current steps showed that both small (Cntnap2+/+, n = 23 cells; Cntnap2/, n = 21 cells) and medium (Cntnap2+/+,
n = 20; Cntnap2/, n = 21 cells) diameter Cntnap2/ neurons display increased firing frequency in comparison to Cntnap2+/+ neurons.
(C) Example traces from medium diameter neurons of outward currents evoked by depolarizing pulses. IKD was measured pre- and post-application of 100 nM
DTX. Current voltage relationships for IKD demonstrating increased current inCntnap2
+/+neurons (n = 12 cells) compared toCntnap2/neurons (n = 14 cells) that
was not present following DTX treatment.
(D) Representative images showing Kv1.2membrane staining in DRG neurons fromCntnap2/ andCntnap2+/+mice. Scale bar, 25 mm. Profile plots were used to
define membrane staining.
(E) Cultured DRG neurons from Cntnap2/ mice have less Kv1.2 membrane staining when compared to control neurons. b-III-tubulin used to mark all neurons
(n = 4 coverslips from two independent experiments).
(F) Diagram highlighting the difference in the extracellular domain between the full-length (FL) and the short (SH) CASPR2 isoform.
(G) After 5 DIV, there is a significant reduction in rheobase (EGFP 1 DIV [n = 12 cells] versus EGFP 5 DIV [n = 16 cells]) for WT neurons transfected with a plasmid
containing EGFP only. FL-CASPR2-EGFP (n = 25 cells) overexpression at 5 DIV restores the rheobase to 1DIV measurements. However, overexpression of the
short isoform (SH-CASPR2-EGFP) does not affect rheobase values (n = 9 cells).
(H) After 5 DIV, there is a significant reduction in IKD (EGFP 1DIV versus EGFP 5DIV) forWT neurons transfected with a plasmid containing EGFP only (EGFP 1DIV,
n = 16 cells; EGFP 5 DIV, n = 13 cells). FL-CASPR2-EGFP overexpression at 5 DIV (n = 12 cells) restores the IKD to 1 DIV levels. Overexpression of SH-CASPR2-
EGFP did not affect IKD (n = 12 cells).
(I and J) The restoration of rheobase (I) and IKD (J), due to the overexpression of FL-CASPR2-EGFP at 5 DIV is reduced by the application of DTX. Gray lines show
individual cells before and 5 min after the application of 100 nM DTX. Red lines show the average (rheobase, n = 7 cells; IKD, n = 5 cells).
Data shown as mean ± SEM. For (A)–(C), *p < 0.05, **p < 0.01, ***p < 0.001 versus Cntnap2+/+ group. For (G) and (H), *p < 0.05, **p < 0.01 versus EGFP 24 hr
and +p < 0.05, ++p < 0.01 versus EGFP 5 DIV. For (I) and (J), *p < 0.05, **p < 0.01 versus pre-DTX.
See also Figure S7.
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the FL isoformofCASPR2has a cell-autonomouseffect on a pop-
ulation of small-/medium-sizedDRGcells through its regulation of
Kv1 channel membrane expression.
CASPR2 Is Required for Normal D-Hair Primary Afferent
Excitability
In order to study the effects of CASPR2 on the transduction
properties of peripheral sensory terminals in the hindpaw
glabrous skin, we used the tibial nerve-skin nerve preparation
(Milenkovic et al., 2014) and, given the behavioral findings from
both the CASPR2-Ab-treated and Cntnap2/ mice, focused
on mechanotransduction. Evoked responses to mechanical
and electrical stimuli were assessed. We recorded from Ab
low-threshold rapidly adapting and slowly adapting mechanore-
ceptors (RAM and SAM, respectively), Ad low-threshold mecha-
noreceptors (D-hair afferents; note that these are present
in plantar paw skin; see Discussion), Ad mechano-nociceptors
(A-Ms), C-mechano-nociceptors (C-Ms), and polymodal C-me-
chano-heat-nociceptors (C-MHs) (Figure 6A). Consistent with
previous findings in Cntnap2/ mice (Poliak et al., 2003), we
did not find changes in the conduction velocities of any primary
afferent subtype in mice lacking FL-CASPR2 compared to
Cntnap2+/+ mice (Figure 6B). When using an increasing velocity
or an increasing force protocol (STAR Methods), we observed
no changes in the stimulus-response functions of RAMs,
SAMs, A-Ms, C-Ms, or C-MHs (Figure 6C; Table S6). We did,
however, find markedly enhanced excitability in D-hair primary
afferents. The mechanical stimulation protocol for D-hairs
consisted of a ramp and hold phase and the typical response
of a D-hair from Cntnap2+/+ and Cntnap2/ mice is shown in
Figure 6D. As D-hairs characteristically respond only to moving
stimuli, we initially analyzed the velocity stimulus-response func-
tion during the ramp phase only (Figure S9A). D-hair primary af-
ferents are exquisitely sensitive to slow-moving stimuli (Lechner
and Lewin, 2013). Cntnap2/ D-hairs show significant hyperex-
citability to slow stimulus velocities compared to Cntnap2+/+
D-hairs (Figures 6E, S9B, and S9C). We next analyzed the firing
frequency of D-hairs during the entire stimulus. Compared to
Cntnap2+/+mice, D-hairs from Cntnap2/ mice showed mark-
edly impaired adaption and continued to fire during the static
phase of the stimulus at velocities of 75 mm/s (Figure 6F) and
150 mm/s (Figure 6G). It is unusual for D-hair mechanoreceptors
to fire during the hold phase of the stimulus. However, the
Cntnap2/ D-hair firing frequency was strikingly and signifi-
cantly increased during the stimulus hold phase compared to
Cntnap2+/+ D-hairs (Figures 6H and 6I). On average, only
24.29% ± 6.0% of WT D-hairs responded during the hold phase
of the stimulus while 60.0% ± 7.95% of Cntnap2/ D-hairs re-
sponded (Figure 6J). Finally, to rule out a developmental role of
CASPR2 on target innervation, we assessed D-hair innervation
in both glabrous and hairy skin (Figures S9D and S9E). TrkB is
expressed by low-threshold mechanosensitive afferents and
can be used to mark D-hair lanceolate endings in the skin
(Li et al., 2011). We saw no differences between genotypes in
the number of TrkB-positive lanceolate endings in both glabrous
and hairy skin (Figures S9D and S9E). The loss of CASPR2,
therefore, alters the stimulus response of a surprisingly selective
population of primary afferent terminals, the D-hairs, resulting inenhanced responses to low-threshold mechanical stimuli and
markedly impaired adaption.
Loss of CASPR2 Leads to Dorsal Horn Hyperexcitability
Given the integration of sensory inputs at spinal level and poten-
tial synaptic role of CASPR2, we investigated the role of CASPR2
in dorsal horn processing of nociceptive stimuli. We performed
in vivo extracellular recordings from wide dynamic range (WDR)
dorsal horn neurons. Neurons were characterized from depths
corresponding to the deep dorsal horn laminae (Cntnap2+/+,
650 ± 23 mm; Cntnap2/, 602 ± 89 mm) and responded
to mechanical and thermal stimuli in an intensity-dependent
manner.
The reduced mechanical withdrawal thresholds observed
in behavioral assays were supported by enhanced neuronal
response to punctate mechanical stimuli in Cntnap2/ mice
compared to Cntnap2+/+, most notably to noxious intensities
of stimulation (Figure 7A). Heat-evoked responses were less
affected by loss of CASPR2 with heat hypersensitivity only
observed at supramaximal noxious intensities of stimulation
(Figure 7B). This is consistent with the behavioral findings (Fig-
ure 3). Although there was a trend toward increased neuronal re-
sponses in Cntnap2/ mice, we did not observe a statistically
significant difference compared to control in response to dy-
namic brush stimulation of the receptive field (Figure 7C). No
differences were observed between genotypes following appli-
cation of innocuous (acetone) or noxious (ethyl chloride) evapo-
rative cooling (Figure 7D). Receptive field maps were produced
in response to a pinch stimulus applied to the skin; neurons char-
acterized in Cntnap2/ mice exhibited similar receptive field
sizes to neurons from WT littermates (Figure 7E). Electrical stim-
ulation of the receptive field revealed reduced thresholds in
Cntnap2/mice for the activation of A- and C-fibers (Figure 7F).
A train of supra-threshold electrical stimuli (3xC-fiber threshold)
was delivered to the receptive field, and neurons from
Cntnap2+/+ and Cntnap2/ mice exhibited comparable levels
of wind-up (the potentiated response and measure of postsyn-
aptic hyperexcitability) (Figures 7G–7I). The cumulative total of
neuronal events evoked by both A- and C-fibers was increased
in Cntnap2/ mice compared to Cntnap2+/+ (Figure 7G).
Furthermore, the input (the non-potentiated response more
indicative of pre-synaptic events) and post-discharge, a prop-
erty of spinal neurons, were both elevated in Cntnap2/ mice
(Figure 7G). These data demonstrate hyperexcitability within
the pain-signaling pathway at the level of the spinal cord in
Cntnap2/; the modality-specific changes, coupled with alter-
ations in input, but not wind-up, suggest a pre- rather than post-
synaptic locus of action for CASPR2 in regulating dorsal horn hy-
perexcitability. To further address this, we have used spinal cord
slice preparations and recorded from dorsal horn neurons in
Lamina II. We did not see any evidence of altered synaptic func-
tion due to loss of FL-CASPR2. There was no significant differ-
ence in the frequency or amplitude of either spontaneous or
capsaicin-evoked excitatory postsynaptic currents (EPSCs) be-
tween genotypes (Figures S10A–S10C). These findings, coupled
with primary afferent hyperexcitability seen in Figures 4, 5, and 6,
strongly suggest that the increased response measured in WDR
neurons from Cntnap2/ mice has a peripheral locus of action.Neuron 97, 806–822, February 21, 2018 815
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Figure 6. Genetic Deletion of FL-CASPR2 Results in Hyper-Excitable D-Hair Primary Afferents
(A) Diagram illustrating the cutaneous mechanoreceptor sensory endings that were identified and recorded from using the ex vivo skin nerve preparation
(B andC) Conduction velocity (B) andmechanical thresholds (C) were recorded frommechanoreceptors and nociceptors. No differences were observed between
genotypes. See Table S6 for number of recorded units.
(D) Example trace of evoked AP response of both Cntnap2+/+ (top) and Cntnap2/ (bottom) D-hairs following a mechanical stimulus consisting of a ramp phase
and hold phase.
(E) The stimulus response curve showing that Cntnap2/ D-hairs have a significantly higher ramp firing frequency compared to Cntnap2+/+ D-hairs at slow
stimulus velocities.
(F andG)Whole-stimulus (ramp and hold) firing frequencywas analyzed every 100ms to assess D-hair adaptation. At stimulus velocities 75 mm/s (F) and 150 mm/s
(G), Cntnap2/ D-hairs elicited increased firing frequencies and significantly less firing adaptation compared to Cntnap2+/+ D-hairs. Note ramp hold stimulus
below x axis.
(H) D-hair firing frequency was analyzed during the hold phase of each stimulus only. Cntnap2/ D-hairs have a significantly higher firing frequency during the
hold phase than control D-hairs.
(I) The average hold firing frequency to a stimulus (independent of velocity) was significantly increased in Cntnap2/ D-hairs.
(J) The average percentage of D-hairs that responded to a stimulus during the hold phase was significantly higher in Cntnap2/ mice compared to controls.
For (E)–(J), Cntnap2+/+ n = 14, Cntnap2/ n = 20 units recorded from 16Cntnap2+/+ and 15 Cntnap2/mice. Data shown as mean ± SEM. *p < 0.05, **p < 0.01,
***p < 0.001 versus Cntnap2+/+ group.
See also Figure S9.Patient CASPR2-Abs Cause a Loss of Kv1 Channel
Membrane Expression and Hyperexcitability in Sensory
Neurons
Finally, we used cultured mouse DRG neurons to see if plasma
from CASPR2-Ab-positive patients could affect the properties
of these cells in a similar manner to that seen following genetic816 Neuron 97, 806–822, February 21, 2018ablation of FL-CASPR2. At the time of plating, DRG neurons
were treated with complement-deactivated plasmas from the
healthy control subject, patient 1, or patient 2. Initially, we
confirmed the ability of patient Abs to bind sensory neurons
in vitro. Using the anti-human IgG antibody, we saw membrane
staining in patient plasma-treated cells, but not in those treated
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with healthy control plasma (Figures S8D–S8F). Furthermore,
we confirmed the specificity of these patient autoantibodies
for the FL version of CASPR2 by using DRG neurons cultured
from Cntnap2/ mice. No binding of patient IgG was seen on
DRG neurons lacking FL-CASPR2 (Figure S8G). Patient Ab
binding was predominantly seen in NF200-positive cells. In
line with experiments carried out on neurons from Cntnap2/,
we went on to look at the membrane expression of Kv1.2 in cells
treated with plasma for 24 hr at 37oC. Similar to that seen
following genetic ablation of FL-CASPR2, there was a significant
reduction in the membrane expression of Kv1.2 on DRG
neurons treated with patient plasma versus control (control,
35.4% ± 6.4%; patient 1, 12.7% ± 3.6%; patient 2, 17.2% ±
3.5%) (Figures 8A–8C). DRG neurons treated with plasma
from both patient 1 and 2 also had a significant reduction in
rheobase compared to control (Figure 8D). Furthermore, DRG
neurons treated with patient 1 plasma displayed significantly
increased repetitive firing in response to supra-threshold stimuli
compared to control cells, although this effect was not seen in
cells treated with plasma from patient 2 (Figure 8E). These
findings suggest that, as in genetic ablation studies, patient
CASPR2-Abs increase the excitability of DRG neurons due to
reduced Kv1 channel function, and the behavioral hypersensitiv-
ity is mediated via enhanced neuronal excitability rather than
destructive or pro-inflammatory effects.
DISCUSSION
The immune system is increasingly recognized as making an
important contribution to persistent pain states (McMahon
et al., 2015). Hitherto, studies of the immune system in neuro-
pathic pain have focused on immune cells and cytokines while
the role of autoantibodies in persistent pain is less well estab-
lished. Autoantibodies against the VGKCC and in particular to
CASPR2 have been linked to neuropathic pain and furthermore
in some cases pain has been shown to improve following immu-
notherapy (Klein et al., 2012). These clinical findings, in combina-
tion with the phenotype seen in Cntnap2/ mice, suggest that
CASPR2-Abs contribute to pain in these patients. We used pas-
sive transfer of purified IgG from two patients with high titers of
CASPR2-Abs and immunotherapy-responsive pain into mice
and found that IgG was deposited in the peripheral, but not cen-
tral, nervous system (consistent with a peripheral mode of ac-
tion). Both IgG preparations induced mechanical pain-related
hypersensitivity in mice confirming pathogenicity of these anti-
bodies in driving pain-related behavior.Figure 7. Increased Activity of Lamina V/VI Dorsal Horn Neurons to Se
(A and B) Evoked neuronal responses to punctate mechanical stimuli (A) are signifi
mice. Cntnap2/ mice also display increased neuronal responses to heat stimu
(C and D) No significant differences were seen between evoked neuronal respon
evaporative cooling (D).
(E) No differences were seen in the size of the receptive field.
(F) WDR neurons in Cntnap2/ mice display a significantly reduced threshold fo
(G) Cntnap2/ display an increased neuronal response following electrical stimu
(H and I) No difference in the degree of windup was seen between genotypes (H)
both Cntnap2/ and Cntnap2+/+ (I).
Data shown as mean ± SEM, *p < 0.05, **p < 0.01 versus Cntnap2+/+ group. Cel
See also Figure S10.
818 Neuron 97, 806–822, February 21, 2018Autoimmune neuropathies such as Guillain-Barre syndrome
(Ruts et al., 2012) are associated with a high incidence of
neuropathic pain that occurs as a consequence of small fiber
injury. We therefore considered whether CASPR2-Abs caused
pain-related hypersensitivity as a consequence of direct injury
to sensory neurons. We found that the IENFD was unchanged,
and there was no evidence of axon loss or demyelination on
detailed nerve morphometry. Autoantibodies from patients with
rheumatoid arthritis and complex regional pain syndrome can
cause abnormal pain behavior in mice through modulation of
the inflammatory response and altered production of immune
mediators (Te´kus et al., 2014; Wigerblad et al., 2016). We
did not, however, find evidence of a significant inflammatory
response within the peripheral or CNS in mice treated with
CASPR2-Abs, and we hypothesized that CASPR2-Abs altered
sensory function through the novel mechanism of an acquired
channelopathy.
We examined the expression of CASPR2 in sensory neurons
and usedCntnap2/mice to study the effects of CASPR2 levels
on pain-related behavior and primary afferent excitability. A
recent study assessing aCASPR2 reporter line during embryonic
development reported CASPR2 expression in neural circuits
sub-serving multiple sensory modalities including somatosen-
sory afferents projecting to footpad skin and the dorsal horn of
the spinal cord (Gordon et al., 2016). In adulthood, Cntnap2
mRNA was broadly expressed by DRG neurons: it is present
in small diameter DRG cells with unmyelinated axons with
higher expression in those small diameter DRG cells that are
presumptive nociceptors (IB4- and CGRP-positive) versus C
low-threshold mechanoreceptors (TH-positive) (Li et al., 2011).
CASPR2 is expressed at higher levels in medium- to large-sized
cells that are NF200 positive. To address the role of CASPR2 in
sensory function, we initially studied the response ofCntnap2/
mice, which lack the FL version of CASPR2 (FL-CASPR2),
to a diverse range of sensory stimuli. Cntnap2/ mice dis-
played robust hypersensitivity to mechanical stimuli, enhanced
response to supra-threshold noxious heat, and increased noci-
fensive behavior to the chemical algogens capsaicin and
formalin.
Humans with homozygous loss-of-function mutations in
CNTNAP2 demonstrate a number of core features of ASD
(Strauss et al., 2006), and somatosensory abnormalities are
increasingly recognized in ASD patients (Cascio, 2010).
Cntnap2/ mice have been shown to have a number of behav-
ioral features consistent with autism (Pen˜agarikano et al., 2011).
A number of other autism-related genes (Mecp2, Shank3, ornsory Stimuli Cntnap2–/– Mice
cantly greater inCntnap2/ (n = 10 cells) compared toCntnap2+/+ (n = 11 cells)
li (B). Histogram traces represent typical single unit responses.
ses to dynamic brush (C) or innocuous (acetone) and noxious (ethyl chloride)
r both A- and C-fibers following electric stimulation.
lation.
. Representative single-unit traces also shown for the first and last stimulus for
ls recorded from 7 mice per genotype.
A B
D E
C
Figure 8. Patient CASPR2-Abs Reduce Kv1 Membrane Expression on DRG Neurons and Increase Their Excitability
(A) Representative images showing that Kv1.2 (green) membrane staining is decreased in NF200-positive (red) DRG neurons treated with plasma from CASPR2-
Ab-positive patients when compared to control. Scale bar, 25 mm.
(B) Profile plots showing fluorescent intensity for Kv1.2 immunostaining across the cell. The profile suggests that most of the Kv1.2 is internal following treatment
with patient plasma.
(C) Quantification of Kv1.2 membrane staining showing a significant reduction in those cells treated with CASPR2-Ab-positive patient plasma (n = 4 coverslips
from two independent experiments).
(D)Medium-sized DRG neurons treatedwith patient plasma (patient 1, n = 12; patient 2, n = 16 cells) had a significantly reduced rheobase when compared to cells
treated with plasma from healthy control (n = 20 cells).
(E) DRG neurons treated with patient 1 (n = 10 cells), but not patient 2 (n = 15 cells), plasma display increased firing frequency in response to prolonged (500 ms)
graded inputs of current (0–950 pA) in comparison to controls (n = 20 cells). Representative traces are show for each group.
Data shown as mean ± SEM,*p < 0.05, **p < 0.01 versus control group. See also Figure S8.Fmr1) have recently been shown to contribute to sensory disor-
ders via specific roles within primary sensory neurons (Han et al.,
2016; Orefice et al., 2016). Given that genetic or immune-medi-
ated ablation of CASPR2 could cause behavioral hypersensitiv-
ity, we examined the role of CASPR2 in regulating excitability
within DRG cells.
Using in vivo calcium imaging of populations of DRG cells, we
found an enhanced response (in both small- and medium-sized
cells representing both C and Ad fibers) to a range of sensory
stimuli including noxious heat, brush, pinch, and the algogen
capsaicin in Cntnap2/ mice. These data were in agreement
with patch-clamp analysis of dissociated DRG cells in which
small- and medium-sized neurons demonstrated a reduced
rheobase, indicating enhanced excitability. When examining
the peripheral terminals of DRG cells in Cntnap2/ mice, wefocused on mechanical stimulus-response function given that
this was the most striking behavioral finding. We observed
changes inmechanosensitivity in a surprisingly selective popula-
tion of primary afferents, the D-hair mechanoreceptors, which
may indicate that CASPR2 has differential effects on DRG cells
dependent on the compartment examined (i.e., soma versus pe-
ripheral terminal). D-hairs are Ad low-threshold afferents that
form lanceolate terminal endings around hair follicles (Li et al.,
2011), arise frommedium-sized neurons, and show high expres-
sion of Kv1.1 (Shin et al., 2003). Although thought to be present
only in hairy skin, we do find D-hair afferents also in the glabrous
skin of plantar hindpaw. D-hairs are the most mechanically
sensitive of all primary afferents (Lewin et al., 1992). In the
Cntnap2/ mouse, they show increased firing frequency both
in the ramp and hold phases of the mechanical stimulus. Thus,Neuron 97, 806–822, February 21, 2018 819
adaption that is normally very prominent in these afferents was
impaired. In the ‘‘naive state,’’ it was proposed that D-hairs are
involved in priming central mechanisms prior to stimulus detec-
tion from other mechanoreceptors (Lechner and Lewin, 2013).
Recent direct evidence for this arises from experiments in which
optogenetic activation of TrkB expressing afferents (many of
which are D-hairs) results in lowering of mechanical pain thresh-
olds (Peng et al., 2017). Furthermore, in the context of patholog-
ical pain, D-hairs can contribute to the increased pain-related
behavior (Li et al., 2017; Vente´o et al., 2016).
Given the integration of sensory inputs at the level of the spinal
dorsal horn, we undertook extracellular recordings of WDR neu-
rons. There was an enhanced response in Cntnap2/ mice,
particularly to mechanical and noxious heat stimulation. These
neurons also demonstrated a lower response threshold to A-fi-
ber strength and C-fiber strength electrical stimulation. There
was no significant difference in the ‘‘wind up’’ properties of these
neurons; whereas the response to the initial sensory input was
significantly greater suggesting that the locus of action could
be pre- rather than a postsynaptic event. Consistent with this,
we did not observe any change in capsaicin-evoked synaptic re-
sponses in recording from lamina II dorsal horn neurons in
Cntnap2/mice. We subsequently investigated themechanism
by which CASPR2 can regulate primary afferent excitability.
CASPR2 is known to associate with the shaker-type VGKCs.
In Cntnap2/ mice, Kv1 channels no longer cluster at the JXP,
and we found that treatment of mice with human CASPR2-Abs
led to a reduction in the JXP expression of CASPR2 and Kv1.1.
Using Cntnap2/ mice, Poliak et al. (2003) reported that there
was no change in the conduction velocity or the refractory
period. In agreement with this, when using single-unit record-
ings, we also found no change in the conduction velocity of sen-
sory afferents in Cntnap2/ mice. The lack of effect of altered
Kv1 channel distribution in axons is a likely consequence of
the fact that in normal circumstances juxtaparanodal Kv1 chan-
nels are electrically insulated from the node of Ranvier by
compact myelin and do not modulate conduction characteristics
(Rasband et al., 1998). We therefore investigated the function of
CASPR2 in other neuronal compartments: DRG terminals and
soma in which we do find a cell-autonomous effect of CASPR2
on neuronal excitability.
In recordings from cultured DRG neurons, we found that a loss
of the FL-CASPR2 isoform resulted in enhanced excitability
particularly of medium-sized DRG cells. Reduced expression
of Kv1.1 and 1.2 has been associated with increased DRG cell
excitability and enhanced behavioral responses to both noxious
mechanical and thermal stimuli (Chi and Nicol, 2007; Hao et al.,
2013; Zhao et al., 2013). We found a large reduction in the DTX-
sensitive outward current in neurons fromCntnap2/mice, indi-
cating a reduction in the function of Kv1 channels. WT neurons
become hyper-excitable after 5 days in culture co-incident with
reduced CASPR2 expression. This hyper-excitability could be
reversed in an isoform-specific manner: overexpression of
FL-CASPR2, but not of the short isoform, suppressed this hy-
per-excitability in a Kv1 channel-dependent manner. Kv1.1 is
known to be highly expressed by D-hair afferents (Shin et al.,
2003) that may partly explain why this specific population of
afferents showed such enhanced mechanosensitivity of their820 Neuron 97, 806–822, February 21, 2018terminals in the absence of FL-CASPR2. We also observed
enhanced excitability in small DRG neurons from Cntnap2/
mice, although this was less marked than that seen in medium-
sized cells. The relative expression of Kv1 a subunits differs in
distinct DRG neuronal populations with higher expression of
Kv1.1 and 1.2 in medium and large DRG neurons and higher
expression of Kv1.4 in small cells (Rasband et al., 2001). To sum-
marize, CASPR2 is not only important for the longitudinal move-
ment of Kv1 channels to the JXP domain of myelinated axons
(Poliak et al., 2003), but FL-CASPR2 dynamically regulates the
excitability of small- and particularly medium-sized DRG neu-
rons. It is required for the expression of Kv1 channels at the
soma membrane and in its absence these neurons become
hyper-excitable.
We observed deposition of human IgG in the DRG (but not in
spinal cord), and we therefore investigated whether CASPR2-
Abs were able to directly affect soma excitability. IgG from
both patients bound DRG neurons and did indeed increase their
excitability. Binding of IgG, which is divalent, causes target inter-
nalization, which is one of the major pathological mechanisms in
neurological autoimmune conditions (Ludwig et al., 2017). We
found a reduction in Kv1 channel surface expression on DRG
neurons following plasma treatment, consistent with this pro-
posed mechanism. These autoantibodies, therefore, contribute
to clinical pain by directly targeting neuronal molecules that
regulate cell excitability. Although both patient IgGs reduced
rheobase of DRG neurons, only patient 1 IgG enhanced repeti-
tive firing in response to a supra-threshold stimulus. Given that
both antibodies reduce surface expression of Kv1 channels,
this difference is not easy to explain; however, multiple epitopes
within CASPR2 have been shown to be recognized by CASPR2
autoantibodies that could contribute to heterogeneity in their
functional effects (Olsen et al., 2015).
Gene ablation of CASPR2 leads to enhanced pain-related
behavior in response to noxious mechanical, thermal stimuli, or
algogens. This occurs as a consequence of increased DRG
soma excitability due to impaired Kv1 channel function,
increased mechanosensitivity of D-hair terminals, and is also
associated with hyper-excitability at a spinal level. This is a
further example of an ASD-linked gene mutation causing altered
sensory function due to altered transduction/transmission within
DRG neurons. We show for the first time that passive transfer of
human CASPR2-Abs to WT mice can enhance neuronal excit-
ability in a cell-autonomous manner and produce a peripheral
neuropathic pain state as a consequence of an acquired chan-
nelopathy. This demonstrates antibody pathogenicity and, given
the potential reversibility of excitability changes, provides a ratio-
nale for the identification of CASPR2-Abs in chronic pain patients
and the appropriate use of immunotherapy.STAR+METHODS
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Antibodies
Rabbit anti-AFT3 (C-19) Santa Cruz Cat# sc-188, RRID: AB_2258513
Sheep anti-CGRP Enzo Life Sciences Cat# BML-CA1137, RRID: AB_2050885
Rabbit anti-CGRP Peninsula Laboratories Cat# T-4032, RRID: AB_2313775
Isolectin B4 (IB4), conjugated to biotin Sigma-Aldrich Cat# L2140, RRID: AB_2313663
Rabbit anti-PGP9.5 UltraClone Discontinued
Mouse anti-NF200 Sigma-Aldrich Cat# N0142, RRID: AB_477257
Chicken anti-NF200 Abcam Cat# ab4680, RRID: AB_304560
Rabbit anti-CASPR2 Abcam Cat# ab33994, RRID: AB_2083506
Guinea pig anti-CASPR Gift from Bhat MA N/A
Rabbit anti-IBA1 Wako Cat# 019-19741, RRID: AB_839504
Rabbit anti-Kv1.1 Gift from Trimmer J N/A
Mouse anti-Kv1.2 UC Davis/NIH NeuroMab Facility Cat#75-008, RRID: AB_2296313
Mouse anti-Tubulin III, beta Sigma-Aldrich Cat#T8578 RRID: AB_1841228
Rabbit anti-PAX2 Thermo Fisher Scientific Cat# 71-6000, RRID: AB_2533990
Rabbit anti-NeuN Abcam Cat# ab177487, RRID: AB_2532109
Chicken anti-NeuN Millipore Cat# ABN91, RRID: AB_11212808
Goat anti-TrkB R and D Systems Cat# AF1494, RRID: AB_2155264
Sheep anti-Tyrosine Hydroxylase Millipore Cat# AB1542, RRID: AB_90755
Rabbit anti-Gephyrin Frontier Institute Cat# Gephyrin-Rb-Af1330,
RRID: AB_2571705
Goat anti-VGAT Frontier Institute Cat# VGAT-Go-Af620, RRID: AB_2571623
Rabbit anti-c-FOS Santa Cruz Cat# sc-52, RRID: AB_2106783
Rabbit anti-CD3 Abcam Cat# ab16669, RRID: AB_443425
Rat anti-CD68 Bio-Rad Cat# MCA1957, RRID: AB_322219
Rat anti-Gr-1(Ly-6G) R and D Systems Cat# MAB1037, RRID: AB_2232806
Rabbit anti-GFAP Dako Cat# Z0334, RRID: AB_10013382
Chicken anti-GFP Abcam Cat# ab13970, RRID: AB_300798
Donkey anti-rabbit IgG Alexa 488 Thermo Fisher Scientific Cat# A-21206, RRID:AB_2535792
Donkey anti-rabbit IgG Cy3 Jackson ImmunoResearch Labs Cat# 711-166-152, RRID: AB_2313568
Goat anti-rabbit IgG Pacific blue Thermo Fisher Scientific Cat# P-10994, RRID: AB_2539814
Donkey anti-rabbit IgG Alexa 546 Thermo Fisher Scientific Cat# A10040, RRID: AB_2534016
Donkey Anti-sheep IgG Cy3 Jackson ImmunoResearch Labs Cat# 713-166-147, RRID: AB_2340729
Streptavidin Pacific blue Thermo Fisher Scientific Cat# S11222
Streptavidin Alexa 405 Thermo Fisher Scientific Cat# S32351
Donkey anti-mouse IgG Alexa 488 Thermo Fisher Scientific Cat# A-21202, RRID: AB_141607
Goat anti-mouse IgG Pacific blue Thermo Fisher Scientific Cat# P31582, RRID: AB_10374586
Goat anti-guinea pig IgG Alexa 568 Thermo Fisher Scientific Cat# A-11075, RRID: AB_2534119
Goat anti-human IgG Alexa 488 Thermo Fisher Scientific Cat# A-11013, RRID: AB_2534080
Goat anti-human IgG Alexa 546 Thermo Fisher Scientific Cat# A-21089, RRID: AB_2535745
NeuroTrace 530/615 Red Fluorescent
Nissl Stain
Thermo Fisher Scientific Cat# N21482, RRID: AB_2620170
Donkey anti-sheep IgG Alexa 488 Thermo Fisher Scientific Cat# A-11015, RRID: AB_2534082
Goat anti-rat IgG Alexa 488 Thermo Fisher Scientific Cat# A-11006, RRID: AB_2534074
Goat anti-rat IgG Alexa 546 Thermo Fisher Scientific Cat# A11081, RRID: AB_10563603
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Goat anti-chicken Alexa 488 Thermo Fisher Scientific Cat# A-11039, RRID: AB_2534096
Goat anti-chicken Alexa 546 Thermo Fisher Scientific Cat# A-11040, RRID: AB_2534097
Donkey anti-goat Alexa 546 Thermo Fisher Scientific Cat# A-11056, RRID: AB_2534103
Donkey Anti-goat Alexa 488 Thermo Fisher Scientific Cat# A-11055, RRID: AB_142672
Bacterial and Virus Strains
AAV9.CAG.GCaMP6s.WPRE.SV40 UPENN Vector Core Cat# AV-1-PV2833
Chemicals, Peptides, and Recombinant Proteins
a-Dendrotoxin Alomone labs Cat#D-350
Capsaicin Sigma-Aldrich Cat#M2028
Formaldehyde solution Sigma-Aldrich Cat#252549
Acetone WVR Chemicals Cat#20066.321
ethyl chloride Miller Medical Supplies discontinued
Critical Commercial Assays
RNAscope 2.5 HD Reagent Kit-RED Advanced Cell Diagnostics Cat# 322350
Experimental Models: Organisms/Strains
Mouse C57BL/6 Biomedical services Oxford University JAX Mice Stock Number 000664
Mouse Cntnap2/ Peles lab JAX Mice Stock Number: 017482
Mouse GlyT2-EGFP Zeilhofer Lab N/A
Oligonucleotides
For qPCR primers see Table S8 This paper N/A
RNAscope Probe- Mm-Cntnap2 Advanced Cell Diagnostics Cat# 449381
Recombinant DNA
FL-Human-CASPR2-EGFP Irani et al., 2010 N/A
SH-Human-CASPR2-EGFP This paper N/A
pAcEGFP-C1 Clontech Cat# 632470
Software and Algorithms
ImageJ/Fiji NIH https://imagej.nih.gov/ij/index.html,
https://fiji.sc/
Clampfit 10 Molecular Devices http://mdc.custhelp.com/app/answers/
detail/a_id/18779//axon%E2%84%A2-
pclamp%E2%84%A2-10-electrophysiology-
data-acquisition-%26-analysis-software
LabChart v7.3 ADInstruments https://www.adinstruments.com/support/
software/archive
Spike2 Cambridge electronic design http://ced.co.uk/
Mini Analysis software Synaptosoft http://www.synaptosoft.com/MiniAnalysis/
Prism 7.0 GraphPad Software https://www.graphpad.com/
SigmaPlot 13 Systat sotware http://www.sigmaplot.co.uk/CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, David Bennett (david.
bennett@ndcn.ox.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse lines and animal care
All procedures were carried out in accordance with UK home office regulations and in line with the Animals Scientific Procedures Act
1986 at a licensed facility within the University of Oxford, following institutional review board approval. Animals were group housed ine2 Neuron 97, 806–822.e1–e10, February 21, 2018
IVC cages in temperature and humidity controlled rooms where food and water was available ad libitum, with a 12 hour light dark
cycle. The welfare of all animals was continually assessed throughout all procedures.
Cntnap2/mice, were generated by E Peles and have previously been described (Poliak et al., 2003). Thesemiceweremaintained
on a C57BL/6J background. Heterozygous mice were bred together to obtain both Cntnap2/, Cntnap2+/ and Cntnap2+/+ litter-
mates. Genotyping of offspring was performed by PCR of genomic DNA using primers to detect either the wild-type (50-TGC
TGCTGCCAGCCCAGAACTGG-30 to 50-TCAGAGTTGATACCCGAGCGCC-30) or mutated allele (50-AGCAGCCGATTGTCTGT
TGT-30 to 50-CTCACCCAATCTCACAAACAAG-30) of Cntnap2. Glycine transporter 2-eGFP reporter mice have been previously
described (Zeilhofer et al., 2005). Both male and female adult Cntnap2//Cntnap2+//Cntnap2+/+ mice were used for experimental
studies. For human IgG studies male C57BL/6J mice were used. For all behavior and tissue analysis studies, mice were aged be-
tween 8-16 weeks. For cell culture mice were aged between 4-8 weeks. This study conforms to the ARRIVE guidelines.
Cell culture
Adult male and female mice of 4-8 weeks of age were sacrificed in a CO2 chamber. The spinal column was rapidly removed and bi-
sected to reveal the DRG. DRGwere taken from all levels and placed directly into Hanks’ Balanced Salt solution (HBSS without Ca2+
and Mg2+, Invitrogen). DRG were then subjected to enzymatic digestion using collagenase II (12mg/ml, Worthington) and dispase II
(14mg/ml, Roche) diluted in HBSS for 1.5 hours at 37C. DRGs were then washed in HBSS and mechanically dissociated using fire
polished pipettes. Dissociated cells were suspended in culture medium (Neurobasal medium, B27, glutamax, GIBCO) supplemented
with mouse NGF (50ng/ml, Peprotech) and GDNF (10ng/ml, Peprotech), and plated on to laminin/poly-D Lysine coated coverslips
before being incubated at 37C.
Human embryonic kidney 293 (HEK293) cells were cultured in Dulbeccos’s modified Eagles’s medium with 10% fetal calf serum
(TCS Cellworks Ltd) in 6 well plates at 37C. Penicillin G and streptomycin were added to the culture medium to prevent infection.
METHOD DETAILS
IgG purification
The IgG fraction was purified from the plasma of both CASPR2-Ab patients and the healthy control using protein G Sepharose beads
(Sigma). The plasma was diluted 1:4 with Hartmann’s solution and passed through a column containing the Sepharose beads at a
flow rate of 0.5ml/minute. Once the diluted plasma had passed through the column, additional Hartmann’s solution was used to
wash the beads to ensure no non-specific proteins were present. The IgG was then eluted with 0.1M glycine solution (pH 2.3) and
immediately neutralised with 1M Tris (pH 8). Coomassie Plus assay kit (Pierce) was used to determine the protein content of the
eluted fractions. Fractions with high protein content were dialysed against Hartmann’s solution, concentrated using polyethylene
glycol and filter sterilized. IgG concentration was determined by spectrometry. For Patient 1 the purified IgG was concentrated to
15mg/ml, for Patient 2 to 11mg/ml and for healthy control to 15mg/ml and 12.5mg/ml, respectively.
Passive transfer
C57BL/6 male mice (8-12 weeks of age) received daily intraperitoneal injections of sterile purified human IgG for either 2 or 3 weeks.
All injections were given between 5-6pm and were therefore carried out subsequent to any behavioral testing that had occurred the
same day. For experiments involving patient 1, mice received 6mg of purified IgG daily of either patient or healthy control IgG. For
experiments involving patient 2, mice received 10mg of purified IgG daily of either patient or control IgG. Mice were closely observed
throughout the dosing regime and their weight monitored. At termination of the injections, blood was taken for serology and tissue
taken for histology as described below.
Behavioral studies
The same designated room was used for all behavioral studies and testing was performed at a consistent time of day. Mice were
acclimatised to the testing equipment and baseline values were obtained by averaging data from 2-3 sessions. For human IgG
studies, baseline values were used to allocate mice into matching groups prior to treatment. Sample sizes were chosen based on
a power calculation using historical data relating to mechanical and thermal threshold responses (a error of 0.05 and a power of
80%). It was calculated that groups of 8 would be needed, using the assumption that an effect size of 25%would be biological mean-
ingful. In total 45 Cntnap2/ 7 Cntnap2+/ mice and 48 Cntnap2+/+ littermates were used in behavioral studies (56 males and 44
females). Mechanical hypersensitivity was replicated in a second independent cohort of mice. Male C57BL/6 mice were used for
all human IgG studies. In total 17 mice were injected with healthy control IgG, 8 with patient 1 IgG and 9 with patient 2 IgG. For all
behavior experimentsmice fromdifferent experimental groupswere assessed at the same time.Mechanical sensitivity was assessed
by placing mice in a Perspex box situated on top of a wire mesh. Calibrated Von Frey hairs (Ugo Basile) were then applied to the
plantar surface of the hind paw and a reflex withdrawal response was used to calculate the 50% withdrawal threshold (Chaplan
et al., 1994). Dynamicmechanical allodynia was assessed using a recently published protocol (Cheng et al., 2017). A small paintbrush
(5/0, The Art Shop) was modified by trimming the tip to make it blunt. This was used to gently stroke the plantar surface of the paw. A
scoring system was used as follows to determine a dynamic allodynia score, (0) (a none painful response) lifting of the paw for less
than 1 s, (1) sustained lifting of the paw or a single flinch, (2) lateral paw lift above the level of the body or a startle like jump and (3)Neuron 97, 806–822.e1–e10, February 21, 2018 e3
multiple flinching responses or licking of the affected paw. The response to a clear noxious mechanical stimulus was also assessed
using the pin prick test as previously described (Arcourt et al., 2017). A dissecting pin was attached to a 1 g Von Frey filament and
applied to the plantar surface of the hind paw to elicit a rapidwithdrawal reflex. The latency towithdrawwas recorded using an iPhone
6 (Apple) at 240fps (4.16ms per frame) and analyzed using the video editing program Avidemux. Thermal sensitivity was initially as-
sessed using the Hargreave’s method (Hargreaves et al., 1988). Here using the Hargreave’s apparatus (Ugo Baslie) a radiant heat
source was applied to the plantar surface of the hind paw and the latency to withdrawal was used to determine heat sensitivity
threshold. Response to a suprathreshold heat stimulus was measured using the hot plate (Ugo Basile) assay. A metallic plate was
set so that the surface temperature was at either 50Cor 53C.Mice were then placed onto the plate and the latency until a response,
in this case shaking, licking or biting of the paw, was measured. To assess cold sensitivity a thermal preference paradigm was used.
The thermal preference equipment (Ugo Basile) consisted of two plates with a small connecting bridge. The plates were set at either
16C or room temperature. Mice were then assessed over a 10 minute period and the percentage of time spent at 16C was calcu-
lated. Pilot studies had identified this temperature scenario as optimal (data not shown). For assessment of capsaicin sensitivity, mice
received an intraplantar injection of 1.5mg of capsaicin (Sigma) diluted in sterile saline with 1% ethanol and 0.5% tween in a volume of
10 ml. Micewere placed in a Perspex cylinder and the duration of pain-related behavior, biting/licking/paw lifting, was recorded over a
5 minute period. For the formalin test, mice received an intraplantar injection of 20 ml of 5% formalin diluted from formaldehyde so-
lution (Sigma) in sterile saline. Again, mice were placed in a Perspex cylinder and the duration of pain-related behavior, biting/licking/
paw lifting, was recorded over a 60minute period. The behavioral response is biphasic and therefore further comparisons weremade
by pooling data in the first (0-15mins) and second (15-60mins) phases. Motor behavior was assessed using a RotaRod. Mice were
placed on a rotating rod which was either accelerating from 4-32rpm or at a constant speed (28 rpm). The latency until the mouse
could no longer stay on the rod was recorded. For the open field test, a black box displaying a grid system on the floor was used.
Mice were placed in this box for 3 minutes and the number of boxes the mouse entered during this period was recorded. Proprio-
ception was also assessed using the beam walk test as previously described (Carter et al., 2001). This test used a wooden beam of
about 1 m in length which was elevated from the bench surface. Mice were filmed as theymoved along the beam and the percentage
of correct steps was calculated by counting the number of missed steps and comparing to the total number of steps taken for each
run. All behavior studies were carried out with the experimenter blind to treatment group or genotype. No animals were excluded from
the behavioral analysis.
Histology
Tissue preparation
For immunohistochemistry and in situ hybridization studies, mice were overdosed with pentobarbital and transcardially perfused,
initially with sterile saline and then 20mls of 4% paraformaldehyde (PFA, 0.1M Phosphate buffer (PB)). Once dissected the glabrous
skin and sciatic nerves were post-fixed in 4%PFA for 0.5 hours at RT, DRG for 2 hours and spinal cord overnight at 4C. All tissuewas
dehydrated for cyroprotection in 30% sucrose (0.1M PB) at 4C for at least 24 hours. Tissue was then embedded in optimal cutting
temperature (OCT) medium (Tissue-Tek) and stored at 80. Tissue was then placed into a solution containing only 30% sucrose
before being embedded in OCT. Tissue was sectioned onto Superfrost plus slides (VWR) using a cryostat. For skin, gelatine treated
slides were used. Sciatic nerve and DRG sections were cut at 10 mm, skin at 14 mm and spinal cord at 30 mm. The slides were then
stored at 80.
Immunohistochemistry (IHC)
Tissue sections were washed once in PBS and then blocked for 1 hour before being incubated overnight at RT with primary antibody
diluted in PBS triton-X (0.3%) (Table S7). For nodal staining in the sciatic nerve, tissue sections were subjected to a mild antigen
retrieval protocol. This involved placing slides containing tissue sections into an EDTA buffer (10mM tris Base, 1mM EDTA,
0.05% Tween, pH9.0) at 60C for 4-6 hours before blocking and primary Ab incubation. Primary Ab was washed off in PBS triton-X
and tissue was then incubated with secondary antibodies (Table S7) at RT for 3-4 hours. Cultured DRG neurons were fixed in 4%PFA
for 10minutes, washed in PBS, and then incubatedwith primary Ab diluted in blocking solution (Goat or donkey serum, PBS-Tx 0.3%)
overnight at 4C. Coverslips were washed in PBS and incubated with secondary Ab for 2 hours at RT. Immunostaining was visualized
using a confocal microscope (Zeiss) and images acquired using the Zen black software.
Skin whole-mount IHC
Briefly, the hind paw hairy and glabrous skin of mice was dissected and post-fixed in 4% PFA for 2 hours. Following this, samples
were washed in PBS and then bleached in Dent’s Bleach (33%H2O2, 13.3% DMSO, 53.3%methanol), for 24 hours at 4
Cwith rota-
tion. Samples were blocked and incubated with antibodies in the samemanner as mentioned above but with longer incubation times
(primary antibodies 4 days, secondary antibodies, 2 days). Following antibody incubation the tissue was cleared using 50%80%and
100% tetrahydrofuran(THF)/ddH2O for 30 minutes (100% for 1 hour) and then in 10% 25% 50% and 97% 2-2 Thiodiethanol (TDE)/
PBS/ddH2O, for 2 hours at RT. Samples were stored in 97%TDE/PBS and embedded onto microscope slides using 460mm thick
adhesive foam spacers. Immunostaining was visualized using a confocal microscope (Zeiss) and images acquired using the Zen
black software.
In situ hybridization (ISH)
Once cut, sections were air-dried in the cryostat for 0.5 hours and then stored in the80C. ISHwas carried out using the RNAScope
2.5 RED chromogenic assay kit and by following the manufacturer’s instructions (Advanced Cell Diagnostics). Briefly, tissue sectionse4 Neuron 97, 806–822.e1–e10, February 21, 2018
were removed from the80, allowed to equilibrate to RT and re-hydrated in PBS. Pre-treatment required a hydrogen peroxide step at
RT; followed by a protease treatment in a hybridization oven at 40C. Slides were then incubated with the target or control probes at
40C for 2 hours. For CASPR2 mRNA the probes were designed to target position 3708-5086 of NM_001004357.2. Following probe
incubation, slides were subjected to 6 rounds of amplification and the probe signal was developed via a reaction with fast red. To
combine with IHC, tissue sections were then washed with PBS-Tx (0.3%) and subjected to the standard IHC protocol.
Electron microscopy and analysis
Animals which were either treated with purified IgG from either Patient 1, Patient 2 or healthy control were terminally anesthetized
using sodium pentobarbital (Euthatal; 80 mg/kg, i.p.) and transcardially perfused with 0.9% saline followed and 4% PFA in 0.1 M
PB. A section of the sural nerve was taken and post-fixed in 3% glutaraldehyde and 4% PFA in 0.1 M PB) at 4C overnight, washed
in 0.1 M PB, osmicated, dehydrated, and embedded in epoxy resin (TAAB Embedding Materials). Ultrathin sections (90 nm) were
taken using a Diatome diamond knife on the Leica UC7 ultramicrotome and mounted onto 200 mesh Cu grids. Sections were
post-stained with Reynold’s lead citrate for 5 minutes, washed with degassed water and dried. Samples were transferred to a FEI
Tecnai 12 transmission electron microscope and imaged at 120kV. Images were acquired using a Gatan OneView CMOS camera
with Digital Micrograph 3.0 software. Full montages of grid squares were taken (25 pictures permesh) and randomly chosen images
from a given grid square were analyzed. The total number of axons, total number of myelinated axons, Schwann cell-myelinated
axons, were counted from these montages of grid squares and normalized to the total area. To calculate G-ratios, axon diameters
and non-myelinated axons with a diameter > 1 mm, individual pictures at the same magnification were randomly chosen per animal;
analysis was performed on all of the axons within each picture and axon diameter and G-ratio (axon diameter/fiber diameter) were
calculated using AxioVision LE Rel. 4.2 Software. The examiner was blind to the treatment group.
Image Analysis
Analysis of the signal intensity for in situ hybridization studies on DRG was calculated using ImageJ software. In a single image of a
section of either L4 or 5 DRG, neurons with a nucleus were circled and the percentage coverage of red signal for that cell profile area
measurement was calculated. By eye the cell was then subpopulation defined by using primary antibodies against NF200, IB4, CGRP
or TH and the appropriate secondary antibody (Table S7). For each marker at least 3 sections were imaged per animal. On each im-
age a background reading was taken from an area of tissue not containing neuronal cell bodies. An average of this was calculated for
each animal and any cell that had percentage coverage of greater than 2 standard deviations from the background mean were
defined as being positive for CASPR2mRNA. For spinal cord sections, CASPR2mRNA positive cells were defined as those contain-
ing 4 or more red dots and the percentage of Pax2 expressing cells positive for CASPR2 mRNA was calculated. For analysis of
neuronal activity following formalin (5%) injection, Cntnap2/ and control mice were perfused two hours post injection and tissue
was incubated with a primary antibody against c-fos (Table S7). NeuNwas used to mark neuronal cell bodies (Table S7). The average
number of c-fos positive neurons in the dorsal horn was calculated from 3-5 sections per animal for both ipsilateral and contralateral
sides. For the quantification of DRG neuron subpopulations inCntnap2/mice, 3 sections of the L4 DRGwere imaged and used for
each animal with > 100 cells counted for each subpopulation. The number of cells for each marker is shown as a percentage of the
sum of NF200, IB4 and CGRP positive cells. For intraepidermal nerve fiber density counts, 3-4 sections of glabrous skin taken lateral
to the proximal end of the most proximal walking pad were used and imaged for each animal. Nerve fibers were identified using a
primary antibody against PGP9.5 (Table S7). The numbers of free nerve endings in the epidermis were calculated using the EFNS
guidelines which meant that only fibers that penetrated into the epidermis from the dermal layer were counted. For analysis of
Pax2 positive inhibitory interneurons inCntnap2/mice, tissuewas incubated in primary antibody against Pax2 (Table S7) and 3 sec-
tions from the L4 segment of the mouse spinal cord were scanned. The number of Pax2 positive neurons in a 10mmdepth across the
dorsal horn was calculated and shown as the percentage of total neurons (NeuN positive). For human IgG binding studies sciatic
nerve, DRG and spinal cord sections were analyzed. Sciatic nerve sections were incubated with a primary antibody against the para-
nodal marker CASPR, DRG sections with a primary antibody against NeuN tomark neuronal cell bodies and spinal cord sections with
Nissl to mark neurons and DAPI for distinguishing cell nuclei (Table S7). Sections were then incubated in the appropriate secondary
antibodies including anti-human IgG to visualize CASPR2-Ab binding in vivo (Table S7). Permeabilised (0.3% Triton-X) naive wild-
type sciatic nerve sections were incubated with purified patient IgG and an antibody against CASPR (paranode) to show the ability
of CASPR2-Abs to bind in the sciatic nerve when it has access to the JXP. For analysis of immune cell infiltration in mice treated with
purified human IgG from either healthy control or CASPR2-Ab positive patients, primary antibodies against IBA1, Ly6G andCD3were
used to mark, macrophages, neutrophils and T lymphocytes, respectively (Table S7). All of these markers were used to analyze DRG
and spinal cord tissue and a primary antibody against NeuN was used to mark neuronal cell bodies. IBA1 was also used in sciatic
nerve sections. Between 3 and 7 sections were imaged for each animal and the average number of cells per image calculated. Astro-
cyte activity was measured using a primary antibody against GFAP (Table S7). The intensity of the GFAP signal in the superficial dor-
sal horn was measured using the analysis tool in ImageJ and an average taken from 3-5 sections were animal. L4 DRGs were also
used for ATF3 analysis. Tissuewas incubatedwith a primary antibody against AFT3 (Table S7) and 3 sections per animal were imaged
and the number of ATF3 positive cells was calculated as a percentage of total neurons using a nissl counterstain (Table S7). For nodal
counts 3 sciatic nerve sections were imaged for each animal. For the calculation of the number of total nodes, an antibody against
CASPR (Table S7) was used to mark the paranode. The number of CASPR positive nodes were counted and shown as the number of
nodes per 1000mm2 of sciatic nerve. Antibodies against CASPR2 and Kv1.1 (Table S7) were used to mark nodes for these proteins
and their amount was calculated as a percentage of total CASPR positive nodes. For analysis of the area of CASPR2 and Kv channelNeuron 97, 806–822.e1–e10, February 21, 2018 e5
immunostaining in the JXP thresholding of the images was performed using the default setting in the ImageJ software. This helped to
remove background noise and the area of immunostaining was then measured for the JXP region of each node, where a node was
defined by being CASPR positive. For tissue analysis composite images are shown. All quantification was performed with the exper-
imenter blind to treatment groups.
Brain tissue processing and microglia analysis
Brains were removed and post-fixed for 24 hours at room temperature before transferring to 40% sucrose in PBS-azide (0.01%).
Using a freezing stage sledge microtome, free-floating coronal sections were collected in 15 series at a thickness of 50 mm. Similar
to that recently described (Coutinho et al., 2017), reactive microglial cells were identified by immunofluorescence using rat anti-CD68
and rabbit anti-IBA1 primary antibodies (Table S7) on free-floating sections. Sections were fixedwith 4% formaldehyde, washed with
PBS then blocked with 10% normal goat serum in PBS-Triton X-100 (0.3%) for an hour then incubated for 48 hours with primary an-
tibodies at 4C. The sections were washed the next day with PBS-Triton X-100 (0.3%) then incubated for three hours at room tem-
perature with goat anti-rat (488) and goat anti-rabbit (568) Alexa Fluor secondary antibodies (Table S7) and kept in the dark. Sections
were subsequently washed in PBS-T (0.3%), final wash was in PBS then sections were mounted on slides after a brief TNS wash
(pH = 7.4) and counterstained with DAPI mounting medium from Vector Laboratories (UK), left to dry for an hour then sealed and
stored protected from the light at 20C until ready for confocal imaging.
Quantification of activated microglia (defined as CD68/IBA1 positive cells) was performed in layers I, II-IV and V-VI in the primary
somatosensory cortex (Bregma 1.46 mm). The area was 110.87 mm x 110.87 mm in (x,y) and the z-step/interval was 2 mm and
microglial cells were counted within a 50 mm depth. 8 z stacks for layer I and 6 stacks for remaining layers were imaged. An
average density was obtained (cells/mm3) in both hemispheres. At least 150 cells per layer per condition were counted. Microglial
morphology was assessed in 20 confocal z stacks/case at 40X magnification (26 mm thickness with imaging every 2 mm) detecting
fluorescence in IBA1 expressing cells in layers of the somatosensory cortex. Minimum resolution of 512x512 was used and with a
line averaging of 4 to allow for a detailed assessment of microglial cells in each group. A macro (see below) from Fiji (image anal-
ysis software) was used to obtain in each stack a clear representation of the cell body and processes of 100 microglial cells per
group. Soma size (mm2) and number of processes per cell was recorded manually in Fiji. Microglia morphology macro: run(‘‘Z Proj-
ect...,’’ ‘‘projection=[Max Intensity]’’); run(‘‘Duplicate...,’’ ‘‘duplicate channels=3’’); setAutoThreshold(‘‘Huang’’); setOption(‘‘Black-
Background,’’ false); run(‘‘Convert to Mask’’); run(‘‘Despeckle’’); run(‘‘Invert’’); run(‘‘Analyze Particles...,’’ ‘‘size=500-Infinity pixel
show=Masks clear’’);
IHC of synaptic proteins
Rabbit anti-Gephyrin antibody and goat anti-VGAT antibody were used to identify the post-synaptic density of symmetric synapses,
and IB4 conjugated to biotin was used to label non-peptidergic primary afferents (Table S7). 30 mm sections were mounted onto
SuperFrost slides, air-dried for 48 hours, rehydrated in PBS for 15 min then placed in a solution of 50% ethanol: PBS-Azide
(0.01%) for 30 min at room temperature. Sections were treated in citrate-EDTA buffer (10 mM citric acid, 2 mM EDTA, 0.05%
Tween-20 at pH = 6.2) to a heat-mediated antigen retrieval step in citrate buffer for 10 min. Proteinase K treatment (4 mg/mL) for
10 min followed by a 10 minute pepsin treatment (0.1 mg/mL) at 37C in 0.2N HCl solution was performed. Sections were incubated
with primary antibodies diluted in PBS containing 0.3% Triton X-100 & 0.1% azide (PBSTxAz) for three days at room temperature,
washed, then incubated overnight with anti-rabbit and anti-goat secondary antibodies conjugated to Alexa Fluor 488 and Alexa Fluor
546 respectively, and streptavidin conjugated to pacific blue in PBSTxAz (Table S7). Sections were washed; mounted in vectashield
and stored at 20C prior to confocal imaging.
Confocal imaging and analysis of synapses
Images were captured on the Zeiss LSM 700, using 405nm, 488nm and 546nm diode lasers. One z stack per section was taken at an
interval of 0.1 mm across the central portion of the superficial dorsal horn, covering lamina 1-3 dorsoventrally. Approximately 50 op-
tical sections per image were taken for analysis.
All image processing and analysis was performed in ImageJ. Z stacks were deconvolved using theWPL deconvolution algorithm in
the Parallel Iterative Deconvolution ImageJ plugin (Wendykier and Nagy, 2010) based on the Iterative Deconvolve 3D algorithm, uti-
lizing a theoretical 3D point spread function generated in PSF Lab. Image stackswere filteredwith a 3x3median filter and thresholded
using the OTSU method. Lamina 1, 2outer, 2inner and 3 were defined using IB4 labeling, and saved to the ROI Manager. To assess
synapse profile density in each lamina, individual z-slices separated by 0.4 mmwere isolated and gephyrin+ & VGAT+ synaptic puncta
profiles were analyzed separately and for each lamina using the Analyze Particles algorithm in ImageJ. Puncta profile counts in each
lamina were averaged over three sections per animal, and plot as profile counts per 100 mm2.
RNA isolation and cDNA synthesis
Mice were culled using a CO2 chamber. Dissected DRGs were immediately frozen on liquid nitrogen and stored at 80. RNA was
isolated using a combination of TriPure (Roche) and a High Pure RNA tissue kit (Roche). Briefly, tissue was homogenized in Tripure
using a handheld homogenizer (Cole-Parmer) treated with chloroform and then subjected to column purification before being eluted
in RNase free water. Synthesis of cDNA was carried out using Transcriptor reverse transcriptase (Roche), random hexamers (Invi-
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Quantitative Real Time PCR
For analysis of mRNA expression using SYBR green cDNA (5ng) and primers (0.5mM) were mixed with LightCycler 480 SYBR Green
Master (Roche) in a 1:1 ratio and added to white 384 well plates (Roche). Plates were run on a 45 cycle protocol using the LC 480 II
system (Roche). Primers were designed using Primer-BLAST (https://www.ncbi.nlm.nih.gov/tools/primer-blast/). Primer efficiency
and specificity were validated before experimental use. Gene expression for each target primer was normalized against 3 reference
genes (18 s, GAPDH and HPRT1) using the delta delta CT method. Primer sequences are shown in Table S8. For mRNA expression
analysis by means of Taqman technology, custom-made microfluidic Taqman array cards were designed. These cards contained
primers and probes to detect a number of pain-related genes as well as 3 reference genes (18 s, GAPDH and HPRT1). Each
cDNA sample was diluted in PCR grade water and added to Taqman Universal master mix to produce a final concentration of
1-4ng/ml. Cards were run on a 7900HT Fast Real-Time PCR system (Applied Biosystems) and gene expression calculated using
the delta delta CT method. Assay IDs are shown in Table S8.
Electroporation
Electroporation was performed prior to plating using the Neon transfection system (Thermo Fisher Scientific). Dissociated neurons
were resuspended at 5x106 cells/ml in 10 mL Buffer R with 1 mg of total plasmid DNA. The electrical protocol applied was three 1500 V
pulses of 10 ms duration. After electroporation cells were immediately plated as described above.
Plasmid construction
A plasmid containing full length (FL) human CASPR2 tagged with eGFP was generated as previously described (Irani et al., 2010). This
plasmidwas used to generate the plasmid containing the short form of CASPR2 (ENST00000463592.3). A PCR reactionwas set up us-
ing DNA from the plasmid containing FL-CASPR2 and the short transcript isoformwas amplified using the following primersGATCCTC
GAGATGTCGTCCGCCACCGAC and GATCCCCGGGAAATGAGCCATTCCTTTTTGCTT. These primers were also used to add XhoI
and XmaI restriction sites to the 50 and 30 ends, respectively. This product was run on an agarose gel and extracted using a DNA gel
extraction kit (QIAGEN). The DNA plasmid was digested with XmaI and XhoI to remove the FL-CASPR2 sequence. The SH-CASPR2
sequence was then ligated into the cut plasmid using T4 ligase at 16C overnight. The DNA plasmid was sequenced to confirm insert
of the SH-CASPR2 isoform in frame with eGFP. A plasmid containing EGFP only was used as a control (pAcEGFP-C1, Clontech).
Cell based assay
Patient and health volunteer serum were initially tested for antibodies against CASPR2 and other related proteins such as LGI1, as
previously described (Irani et al., 2010). Briefly, Human embryonic kidney 293 (HEK293) cells were cultured in Dulbeccos’s modified
Eagles’s medium with 10% fetal calf serum (TCS Cellworks Ltd) in 6 well plates at 37C. Penicillin G and streptomycin were added to
the culture medium to prevent infection. Cells were transfected with a plasmid containing either full length or the short isoform of hu-
man CASPR2 tagged with eGFP. Forty-eight hours after transfection, live HEK cells were treated with diluted serum from patients or
healthy control. Samples were diluted in Dulbecco’s modified Eagles’s medium buffered with HEPES plus 1%bovine serum albumin
and a scoring system of 0-4 was used; where 0 indicated no human IgG binding and 4 very high levels of binding. Samples were
titrated until a score of 0 was achieved. Titers indicate the last dilution when a score of 1 was given. This same protocol was used
on human plasma and purified IgG as well as mouse samples.
Treatment of DRG neurons with human plasma
Plasmawas obtained from both CASPR2-Ab positive patients. Before being used on cells, plasmawas heated to 56C for 30minutes
to inactivate any potential complement and then placed on ice. Plasma was then added at a concentration of 1:100 to cell cultured
medium and added to the cells 3 hours after plating. Electrophysiological recording were performed 1 and 2 days post plasma treat-
ment. For analysis for Kv1.2 staining, cells were fixed 1 day after treatment.
Quantification of membrane Kv1.2
For analysis of DRG neurons from Cntnap2/ mice, cells were cultured for 1 day. For plasma analysis, cells were cultured in the
presence of plasma for 1 day. Following fixation DRG coverslips were treated with primary antibodies against Kv1.2, NF200 and
Beta-III Tubulin and the appropriate secondary antibodies (Table S7). Coverslips were then imaged using a confocal microscope
and around 20 images were taken from each coverslip using the x40 objective. Using ImageJ software profile plots of each cell
were made spanning the cell diameter for kv1.2 immunoreactivity and a background reading was also taken. An average of the signal
intensity was then taken for the portion of the plot relating the membrane and that relating to the cytoplasm (avoiding the nucleus).
Only signal intensities greater than background were used. A ratio of membrane to cytoplasm was calculated and those cells with
greater than 1.5 times cytoplasm intensity were defined as being kv1.2 membrane positive.
Electrophysiology
Patch clamping of DRG neurons in vitro
Whole-cell patch clamp recordings were performed at room temperature (22) using an Axopatch 200B amplifier and Digidata
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(470/40x excitation filter, dichroic LP 495 mirror and 525/50 emission filter). Data were low-pass filtered at 2 kHz and sampled at
10 kHz. Series resistance was compensated 70%–90% to reduce voltage errors. Patch pipettes (2–4MU) were pulled from filamental
borosilicate glass capillaries (1.5 mm OD, 0.84 mm ID; World Precision Instruments). Current clamp; Patch pipettes were filled with
internal solution containing (mM): 130 KCl, 1 MgCl2, 5 MgATP, 10 HEPES, and 0.5 EGTA; pH was adjusted to 7.3 with KOH and os-
molarity set to 305mOsm. Extracellular solution contained (mM): 140 NaCl, 4.7 KCl, 1.2 MgCl2, 2.5 CaCl2, 10 HEPES and 10 glucose;
pH was adjusted to 7.3 with NaOH and osmolarity was set to 315 mOsm. a-Dendrotoxin (a–DTX, Alomone) was prepared as a
10,000x stock in H2O and added via the perfusion system. Unless otherwise stated, post-DTX recordings were always made 5 mi-
nutes after addition of the drug. Resting membrane potential was assessed in bridge mode, while firing properties were assessed in
current clamp mode. Input resistance (RInput) was calculated from the voltage deflections caused by increasing (D20 pA) hyperpo-
larising current pulses. To determine rheobase, cells were depolarised from a holding potential of 60 mV by current steps
(50 ms) of increasing magnitude (D25 pA) until an action potential was generated. Repetitive firing was assessed by 500 ms depolar-
ising current steps of increasing magnitude (50pA). Voltage clamp. Patch pipettes were filled with internal solution containing (mM):
120 K+ gluconate, 20 KCl, 2MgCl2, 10 EGTA, 10 HEPES, 1 CaCl2 and 5MgATP; pHwas adjusted to 7.3 with KOH and osmolarity was
set to 305 mOsm. Extracellular solution contained (mM): 150 Choline-Cl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 0.1 CdCl2 and
10 glucose; pH was adjusted to 7.4 with KOH and osmolarity was set to 315 mOsm. Outward currents were elicited by depolarising
the membrane potential from 70 to +40mV for 500ms in 10mV increments, following a 1 s pre-pulse conditioning step to 40mV.
The outward current generated at the end of the depolarising pulse was taken as IKD. DTX sensitive currents were obtained by sub-
tracting IKD post-DTX from pre-drug levels. Data were analyzed by Clampfit 10 software (Molecular Devices)
Ex vivo skin-nerve preparation
Skin-nerve primary afferent recordings were conducted in a similar fashion to Milenkovic et al. (2014). Briefly, the hind paw glabrous
skin and tibial nerve were dissected from adult male and female Cntnap2+/+ (n = 16) and Cntnap2/ (n = 15) mice. The skin was
maintained in a perfusion chamber in the outside out configuration (epidermis facing up). The chamber was constantly perfused
with synthetic interstitial fluid (SIF: 2.0mM CaCl2, 5.5mM Glucose, 10mM HEPES, 3.5mM KCL, 0.7 mM MgSO4, 123mM NaCl,
1.5mMNaH2PO4, 9.5mMNa-gluconate, 7.5mMSucrose, 1MNaOH; dH20) at 32
C. Nerve filaments from the tibial nerve were sepa-
rated and placed onto a silver recording electrode. To assess conduction velocities and to characterize fiber types, receptive fields
were electrically stimulated with pulsed supra-threshold currents. The skin was stimulated mechanically using a 0.8mm diameter
probe attached to a piezo electric stimulator (Physik Instrument), or a NanoMotor stimulator (Kleindiek), both in conjunction with force
sensors (Kleindiek). Stimuli of increasing velocities or forces were applied to identify receptive fields on the skin. Stimulus response
functions and AP adaptation properties were analyzed in both the ramp and hold phase of themechanical stimulus. All stimuli evoked
action potentials were visualized using an oscilloscope and recorded using a Powerlab 4.0 system in conjunction with LabChart v7.3
software (ADInstruments).
Extracellular dorsal horn recording
In vivo electrophysiology was conducted on Cntnap2+/+ and Cntnap2/ male and female mice aged between 9 and 11 weeks old.
Animals were initially anaesthetised with 3.5% v/v isofluorane delivered in 3:2 ratio of nitrous oxide and oxygen. Once areflexic, mice
were secured in a stereotaxic frame and subsequently maintained on 1.5% v/v isofluorane for the remainder of the experiment. A
laminectomy was performed to expose L3-L5 segments of the spinal cord. Extracellular recordings were made from deep dorsal
horn wide dynamic range (WDR) lamina V/VI neurones with receptive fields on the glabrous skin of the toes using 0.127 mm 2 MU
parylene-coated tungsten electrodes (A-M Systems). Neurones were characterized from depths relating to deep dorsal horn laminae
(350-700 mm from surface of cord), and were selected on the basis of responses to dynamic brushing, and noxious mechanical and
thermal stimulation. Electrical stimulation of WDR neurones was delivered transcutaneously via needles inserted into the receptive
field. A train of 16 electrical stimuli (2 ms pulses, 0.5 Hz) was applied at three times the threshold current for C-fiber activation. Re-
sponses evoked by A- (0–50 ms) and C-fibers (50–250 ms) were separated and quantified on the basis of latency. Neuronal
responses occurring after the C-fiber latency band were classed as post-discharge (PD). The input (I) and the wind-up (WU) were
calculated as: Input = (action potentials evoked by first pulse) 3 total number of pulses (16), wind-up = (total action potentials after
16 train stimulus) Input. The receptive field was also stimulated using a range of natural stimuli (brush, von Frey filaments – 0.4, 1, 4,
8 and 15 g and heat – 32, 37, 42, 45 and 48C) applied over a period of 10 s per stimulus and the evoked response quantified. The heat
stimulus was applied with a constant water jet onto the center of the receptive field. Acetone (Sigma) and ethyl chloride (50 ml) (Miller
Medical Supplies) were applied to the receptive field, described previously as an evaporative innocuous cooling and noxious cooling
stimulus respectively. Evoked responses to room temperature water (25C) were subtracted from acetone and ethyl chloride evoked
responses to control for any concomitant mechanical stimulation during application. Natural stimuli were applied starting with
the lowest intensity stimulus with approximately 30 s between stimuli in the following order: brush, von Frey, cold, heat, electrical.
Receptive fields were determined using a pinch stimulus. An area was considered part of the receptive field if a response of > 30
action potentials over 5 s were obtained. A rest period of 30 s between applications was used to avoid sensitization. Receptive field
sizes are expressed as a percentage area of a standardized paw measured using ImageJ (NIH, Bethesda). Data were captured and
analyzed by a Cambridge Electronic Design 1401 interface coupled to a computer with Spike2 software (CED, Cambridge, UK) with
post-stimulus time histogram and rate functions. A total of 11 neurones were characterized from 7Cntnap2+/+ mice, and 10 neurones
from 7 Cntnap2/ mice.e8 Neuron 97, 806–822.e1–e10, February 21, 2018
Spinal cord slice preparations
Cntnap2+/+ (n = 7) and Cntnap2/ (n = 6) mice 5-8 weeks old were decapitated under general anesthesia with isoflurane (1%–3%).
The spinal cord was isolated in ice cold dissecting solution that contained the following (in mM): 3.0 KCl, 1.2 NaH2PO4, 0.6 CaCl2,
6.5 MgCl2, 26 NaHCO3, 25 glucose, 240 sucrose, oxygenated with 95% O2 and 5% CO2. The dura mater was removed and ventral
and dorsal roots were trimmed from the cord. The lumbar segment was cut in parasagittal slices (300 mm) with a vibrating blade
microtome (MicromHM 650V, Fisher Scientific). Slices were kept at room temperature for at least 30 min in recording solution
that contained the following (in mM): 127 NaCl, 3.0 KCl, 1.2 NaH2PO4, 2.4 CaCl2, 1.3 MgCl2, 26.0 NaHCO3, 15 glucose, oxygenated
with 95% O2, 5% CO2.
Cells targeted for patch-clamp recording were selected within the superficial dorsal horn (mostly lamina II), which was visualized
under infrared differential interference contrast microscopy on an Olympus BX51WI microscope. Patch pipettes were pulled with a
horizontal puller (P-97, Sutter Instruments) from glass capillaries (World Precision Instruments). The pipettes had an electrical resis-
tance of 4 - 6MU when filled with internal solution that contained the following (in mM): 130 potassium gluconate, 10 KCl, 2 MgCl2,
10 HEPES, 0.5 EGTA, 2 ATP-Na2, 0.5 GTP-Na, pH adjusted to 7.3 with 1 M KOH. Patch-clamp signals were amplified and filtered
(4 kHz low-pass Bessel filter) with a MultiClamp 700B amplifier (Molecular Devices) and acquired at 10 kHz using a Digidata
1440 A A/D board and pClamp 10 software (Molecular Devices).
Spontaneous EPSCs (sEPSCs) were recorded in dorsal horn neurons which were voltage-clamped at 60mV. To excite central
terminals of TRPV1 positive C-fibers, capsaicin (1 mM) was bath applied. Three minutes of raw traces were selected for analysis,
in baseline and during peak evoked sEPSC response (typically a fewminutes after the start of bath application of capsaicin). sEPSCs
were detected offline, using Mini Analysis Program software (Synaptosoft).The investigator was blinded to the genotype of the an-
imals until analysis of each recorded cell was complete. A total of 15 cells was collected from Cntnap2/ mice and 16 cells from
Cntnap2+/+ animals. To assess whether there was a selective response to excitation of central C-fiber terminals either in Cntnap2/
and Cntnap2+/+ mice, the frequency of capsaicin evoked sEPSCs was analyzed. Also, the mean amplitude of these evoked sEPSCs
was compared, between genotypes.
AAV injections for DRG GCaMP6 expression
Mice were anaesthetised using isoflurane (2% O2) and their body temperature maintained around 37
C. After an initial skin incision
over the lumbar region of the spinal cord the intervertebral space between T12 and T13 was exposed. A small catheter (0.2 mm Ø,
Braintree Scientific) was inserted under the dura in the caudal direction through a small cut. A volume of 5ul of AAV9.CAG.
GCaMP6s.WPRE.SV40 (UPENN Vector Core, AV-1-PV2833, 1.1x1013 g/ml) was infused at a rate of 1.2ml/min after which the can-
nula remained subdural for a further 2 minutes before withdrawal. The skin was sutured and Carprieve (0.025 mg; Norbrook Labo-
ratories) was administered subcutaneously for post-operative pain management. The mice were allowed to recover for 0.5-2months
before in vivo calcium imaging
In vivo calcium imaging of DRG
Cntnap2+/+ (n = 4) and Cntnap2/ (n = 5) mice were anaesthetised using urethane (12.5%w/v) injected intraperitoneally (IP). The
initial dose of 37.5mg (0.3ml) was administered to all mice and further doses (approximately 15 minutes apart) were titrated to the
level of anesthesia until surgical depth was achieved. Core body temperature was maintained around 37C using a homeothermic
heating mat (FHC) with feedback from a rectal probe. A tracheal tube was installed but mice breathed freely.
Hair was removed and an incision was made in the skin between L3 – L5 spinal segments. The connective tissue and muscle were
removed on and around the vertebrae and a small laterally extended laminectomy was performed around the L4 DRG. The dura and
perineuriumwere left intact and covered using silicone elastomer (World Precision Instruments, Ltd). The spinal columnwas clamped
using vertebral clamps (Precision Systems and Instrumentation) and stabilized on a custom made stage. An Eclipse Ni-E FN upright
confocal/multiphoton microscope (Nikon) was used to acquire images using a 10X dry objective. A 488 nm Argon ion laser line was
used for excitation and GCaMP signal was collected at 500-550 nm. Time series recordings were typically recorded at 4hz with an in-
plane resolution of 512 3 512 pixels and a fully open pinhole.
While imaging the response of the DRG, eight brush stokes were applied onto the ipsilateral paw at approximately 0.5hz in the
medial to lateral direction. Pinch was applied with an arterial clamp (World Precision Instruments, Ltd) in 4 positions on the paw:
at the ankle, between the ankle and the walking pads, along the walking pads and across the toes. Thermal stimulation (50C)
was applied to the hind paw through a Peltier device (TSAII, Medoc) with a 16x16mm probe. Capsaicin cream (10%) was applied
at the end of the experiment to both the hairy and plantar surface of the skin and assessed for 5 minutes after application was
completed.
The acquired images were drift corrected using NIS Elements AR 4.30.01 (Nikon, align application). The raw data was background
subtracted and normalized by subtracting the baseline and dividing the difference with the baseline to generate DF/F. Regions of
interest (ROIs) around neuronal cell bodies were chosen using a free hand selection tool in Fiji/ImageJ Version 1.48v. ROIs to deter-
mine GCaMP fluorescence were chosen stringently, with minimal overlap to ensure less interference from surrounding somata. ROIs
for calculation of neuronal cell body size were then chosen with less stringency, allowing for overlapping regions in which cells are in
close proximity, to reflect a more accurate calculation of cell diameter. Responding cells (if their response was 70% above baseline
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GCaMP expression) and compared between Cntnap2+/+ and Cntnap2/ mice. To assess spontaneous activity, traces of neuronal
GCaMP fluorescence (as DF/F), from the first 8 minutes of baseline, were generated for each neuron. A blinded examiner visually
determined the presence or absence of spontaneous activity, which was expressed as a percentage of spontaneously active neu-
rons per total number of neurons in each DRG.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data is shown as the mean ± SEM, unless otherwise stated. A Student’s t test was used to compare the mean of two groups and
when data was not normally distributed a non-parametric test was applied (Mann-Whitney). A one-way ANOVA was used when
more than two groups existed. For behavioral studies over time, a repeated-measures two-way ANOVA was used with Holm-Sidak
posthoc analysis. For In vivo calcium imaging an ANOVA on ranks was performed. For patch clamp experiments multipleMann-Whit-
ney tests were used for repetitive firing assays on DRG cells and a two-way ANOVA with Holm-Sidak posthoc analysis for current
voltage relationships. For pre and post DTX treatment a paired t test was performed. For ex vivo skin nerve preparation data a
two-way ANOVA or a two-way repeated-measure ANOVA with Bonferroni posthoc analysis was used. For dorsal horn recordings
a two-way repeated-measure ANOVA with Bonferroni posthoc analysis was applied. Sample sizes for each experimental can be
found in the figure legend. Significance for all experiments was placed at p < 0.05. Statistical tests were carried out with GraphPad
prism or SigmaStat.e10 Neuron 97, 806–822.e1–e10, February 21, 2018
